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 The purpose of this study was to examine the effects of exogenous peroxynitrite 
(ONOO-) on the cardiac isoform of the sarco(endo)plasmic reticulum Ca2+-ATPase 
(SERCA2a) and to determine if overexpression of heat shock protein 70 (Hsp70) could 
protect SERCA2a function. To characterize the interaction between SERCA2a and Hsp70, 
cDNAs encoding each protein were co-transfected in human embryonic kidney cells (HEK-
293) using the calcium-phosphate technique. Western blotting confirmed the expression of 
SERCA2a and a ~1.9-fold overexpression of Hsp70 in HEK-293 cells. ONOO- was added 
chronically (250 μM bolus each minute for 10 minutes) to co-transfected HEK-293 cells in 
culture. Maximal Ca2+-ATPase activity (Vmax) was assessed on microsomal fractions isolated 
following exposure to ONOO-. Vmax was reduced by ~20% in HEK-293 cells transfected 
with SERCA2a alone (S2a-pMT2). When Hsp70 was co-transfected with SERCA2a (S2a-
Hsp70), Vmax was fully protected following incubation with ONOO-. Western blot analysis 
showed that there were no changes in FITC binding capacity and 3-nitrotyrosine content in 
any of the groups. However, overexpression of Hsp70 prevented oxidation of SERCA2a, as 
assessed by reactive carbonyl content, following exposure to ONOO- when compared to S2a-
pMT2. In addition, SERCA2a aggregation was lower compared to S2a-pMT2 groups under 
both control and ONOO- conditions. Co-immunoprecipitation of SERCA2a and Hsp70 
confirmed that Hsp70 physically interacts with SERCA2a under all conditions. These results 
suggest that Hsp70 physically binds to SERCA2a and prevents oxidation and aggregation of 
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The role of sarcoplasmic reticulum in excitation-contraction coupling. 
Human locomotion results from a coordinated sequence of contraction and relaxation 
of skeletal muscles. The molecular series of events that give rise to a contraction and 
relaxation cycle have been characterized and are termed excitation-contraction (EC) 
coupling. In brief, EC coupling begins with motor nerve innervation, which depolarizes the 
sarcolemma. Depolarization propagates within the muscle via the transverse-tubule (TT) 
network, thus activating the voltage sensitive dihydropyridine receptor (DHPR). DHPR 
activation causes opening of the ryanodine receptor (RyR), which allows calcium (Ca2+) to 
move down its concentration gradient from the sarcoplasmic reticulum (SR) to the cytosol. A 
rise in cytosolic free Ca2+ concentration ([Ca2+]f) relieves tropomyosin inhibition and allows 
activation of the contractile apparatus (actin-myosin). In order for relaxation to occur the 
sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) must pump large amounts of Ca2+ back 
into the SR. The regulation of Ca2+ release and sequestration from the SR is vital for proper 
EC coupling.  
The SR is a membranous network, which surrounds the actin and myosin filaments 
within skeletal muscle cells. A key structural characteristic of the SR is the formation of a 
triad. Triads are composed of a TT invagination flanked by two SR terminal cisternae, which 
represents the functional calcium release unit. In this region there is a high density of DHPRs 
(located within the TT membrane), RyRs (located within the SR membrane) and 
calsequestrin molecules, which are intimately associated with RyRs in the lumen of the SR. 
The DHPR and RyR form highly organized series of arrays consisting of 4 DHPRs 
physically interacting with every other RyR (for review see; Protasi, 2002). Although 
1 
SERCAs are present at the terminal cisternae, they are most abundant along the longitudinal 
SR, an area that flanks the contractile apparatus. 
 
3-dimensional structure of SERCA and its reaction cycle. 
The SERCA is a ~100 kDa integral membrane protein whose primary function is to 
pump 2 mol Ca2+ from the cytosol to  the lumen of the SR at the expense of 1 mol ATP. The 
amino acid sequence of SERCA was first deduced by MacLennan and colleagues (1985). 
These researchers predicted several domains that comprise SERCA, those being the 
transmembrane domain (10 helices; M1-10), the actuator domain (A-domain), the nucleotide 
binding domain (N-domain) and the phosphorylation domain (P-domain) (MacLennan et al., 
1985). A decade and a half later, Toyoshima and co-workers (2000) confirmed the 
predictions of MacLennan and colleagues (1985) when they successfully crystallized and 
resolved, with high resolution, the 3-dimensional (3-D) structure of SERCA1a using rabbit 
fast-twitch skeletal muscle (Toyoshima et al., 2000).  
Chikashi Toyoshima’s group has revolutionized the understanding of the structure-
function relationships between the domains of SERCA and how each contributes to the 
pumping of Ca2+ across the SR membrane. A simplified schematic of the reaction cycle of 
SERCA is displayed in Figure 1. In brief, when the Ca2+ binding pocket is open to the 
cytosol the enzyme is in the E1 state and Ca2+ will bind to SERCA in a cooperative fashion. 
Ca2+ binding permits ATP to bind to the N-domain. Subsequently, SERCA is 
autophosphorylated and undergoes conformational changes, which exposes the Ca2+ binding 
pocket to the lumen of the SR (E2 conformation). Next, the two Ca2+ ions are expelled, the 































Figure 1: A simplified schematic of the reaction cycle of SERCA. This image was adapted 




At the present time there are approximately 20 crystal structures of SERCA in 7 
different states, which has resolved the entire reaction cycle of SERCA in 3-D (for review 
see; Toyoshima, 2007; Toyoshima, 2008). The four main crystal structures that comprise the 
reaction cycle of SERCA can be seen in Figure 2. When SERCA is in the E2 state, Ca2+ 
displaces H+ and H2O in the Ca2+ binding pocket. The first Ca2+ forms bonds with side chain 
oxygen atoms from Asn768, Glu771 (M5), Thr799, Asp800 (M6), Glu908 (M8) and two 
water molecules (Toyoshima, 2008). The second binding site utilizes oxygen atoms from 
Asn796, Asp800 (M6) and two from Glu309, which acts as the gating residue. The sequential 
binding of two Ca2+ ions causes the M5 alpha helix, the mast of SERCA, which links the 
transmembrane domain to the P-domain, to straighten. This conformational change in M5 
initiates separation of the 3 cytoplasmic domains, which were in close proximity in the E2 
state and permits ATP to bind to the N-domain (Toyoshima, 2007). 
The next step involves the N-domain “capping” or covering the P-domain, which is 
accomplished through the formation of numerous hydrogen bonds around the ATP and Mg2+, 
which links the N-domain and the P-domain. This puts strain on the cytosolic headpiece and 
causes a deflection of the A-domain. These structural changes cause the M1 helix to be 
partially pulled out of the SR membrane and puts a slight bend in the M1 helix. This action 
closes the cytoplasmic Ca2+ gate (Glu309) and thus occludes the two Ca2+ within the 
transmembrane domain (Toyoshima, 2007).   
The γ-phosphate of ATP is transferred to Asp351 and ADP dissociates from SERCA, 
which initiates the separation of the P- and N-domains (Toyoshima, 2007). In order to 
prevent ADP from binding to the N-domain and to restrict access of water to the 




formerly occupied by ADP. These large movements by the A-domain are transmitted to 
helices M1-6, which opens the lumenal gate allowing the bound Ca2+ to be released into the 
SR lumen. Once released 2-3 H+ and water molecules enter the Ca2+ binding pocket in order 
to stabilize the region. The H+ are deposited in the cytosol, but a proton gradient is not 
generated due the permeability of the SR membrane to protons. 
Hydrolysis of the aspartylphosphate is mediated by further rotation of the A-domain, 
which through conformational changes of the TGES loop and Glu183 allows a water 
molecule access to Asp351. Glu183 plays a critical role in hydrolysis as it abstracts a H+ 
from water, thus permitting hydrolysis of pAsp351 (Anthonisen et al., 2006; Toyoshima, 
2008). When the Pi and Mg2+ are released the strain placed on the P-domain is relieved, 
which is transmitted to M1, M2 and M4 and causes the closure of the luminal Ca2+ gate 
(Toyoshima, 2007). The reaction cycle can now proceed again with the binding of Ca2+ to its 
binding pocket.  
The resolution of SERCA1a crystal structures has highlighted the large scale 
movements that are required to transmit the energy derived from Asp351 phosphorylation in 
the P-domain nearly 50 Å to the Ca2+ binding pocket in the transmembrane domain. All of 
these crystallography studies have examined SERCA1a the fast-twitch isoform in adult 








Figure 2: Detailed 3-dimensional representation of the reaction cycle of SERCA. From 
Toyoshima C. Arch. Biochem. Biophys. 476(1): 3-11, 2008. The inset identifies the 
corresponding intermediates within the reaction cycle that the 3-D SERCA1a structures 




SERCA genes and isoforms. 
At the genomic level, there are three ATP2A genes that encode multiple SERCA 
isoforms (Pan et al., 2003; MacLennan et al., 1985; Lytton & MacLennan, 1988; Brandl et 
al., 1986; Burk et al., 1989). Each gene gives rise to two or more alternatively spliced gene 
transcripts, which are ultimately translated into their respective proteins. For example the 
ATP2A1 gene codes for SERCA1b, the isoform abundant in neonatal skeletal muscle and 
SERCA1a, which is the predominant isoform in adult fast-twitch skeletal muscle (Pan et al., 
2003; Wu & Lytton, 1993). SERCA2a is the exclusive isoform expressed in cardiac muscle 
and is present in adult slow-twitch muscle, whereas SERCA2b is the primary isoform in 
vascular smooth muscle. SERCA3 variants are expressed more ubiquitously. Recently, a 
third SERCA2 isoform, SERCA2c has been characterized (Dally et al., 2006). The 
expression pattern of SERCA2c appears to mimic that of SERCA2a, yet the maximal 
catalytic activity of SERCA2c is nearly identical to that of SERCA2b (Dally et al., 2006). 
Using immunocytochemistry of fixed human cardiac tissue these authors found that 
SERCA2c was compartmentalized to regions in the SR that are close to the sarcolemma. The 
study by Dally and co-workers (2006) found that SERCA2c is expressed in distinct areas of 





Manipulation of SERCA isoform expression by chronic low frequency stimulation. 
Since the identification of the genes encoding SERCAs, the regulation of these genes 
and the associated protein expression has been highly investigated. Two models commonly 
employed to alter SERCA1a and SERCA2a expression in skeletal muscle are altered thyroid 
status (i.e. induced hypo/hyperthyroidism) and chronic low frequency stimulation (CLFS).  
When applied to a fast-twitch skeletal muscle, CLFS leads to a progressive shift in 
fibre type to that of a slow-twitch phenotype (Pette & Düsterhöft, 1992). One of the major 
transformations associated with CLFS is a shift in both myosin heavy (MHC) and light chain 
(MLC) isoforms from Type II to Type I (Leeuw & Pette, 1996). During CLFS there is a 
parallel shift in SERCA isoform when compared to that of the MHC isoform, namely the fast 
isoform, SERCA1a is down regulated and the slow isoform, SERCA2a is up regulated (Pette 
& Düsterhöft, 1992). Studies indicate that prior to a significant alteration in the SERCA pool, 
there is a robust reduction in the maximal Ca2+-ATPase activity (Vmax) in the first hours and 
days of CLFS in the extensor digitorum longus (EDL) and tibialis anterior (TA) muscles of 
rat and rabbit (Klebl et al., 1998; Matsunaga et al., 2001). These studies point to protein 
oxidation as the likely mechanism associated with the reduction in ATPase activity. In 
addition, the reduction in enzyme activity measured in vitro is likely underestimated 
considering the pronounced reduction in phosphorylation potential observed during CLFS in 
vivo (Green et al., 1992).  
It was initially believed that the signal responsible for activating the shift in gene 
expression of chronic low-frequency stimulated muscles was the pronounced and sustained 
drop in phosphorylation potential (Pette & Dusterhoft, 1992). Elevations in [Ca2+]f were 




improvements in the sensitivity of Ca2+ fluorophores permitted the measurement of [Ca2+]f in 
muscles during CLFS in the basal state and during contractions (Carroll et al., 1999). Carroll 
and colleagues (1999) found that the resting [Ca2+]f in single fibres from rat EDL exposed to 
CLFS rose significantly within the first 12 hrs of stimulation and remained elevated during 
the 10-day protocol. It is now believed that Ca2+ plays a significant role in initiating gene 
transcription and/or silencing (Chin et al., 1998). 
 
Ca2+ signaling and gene regulation. 
Persistent elevations in [Ca2+]f activate calcineurin, a Ca2+/Calmodulin-dependent 
serine/threonine phosphatase (Chin et al., 1998). Calcineurin has been termed the master 
regulator of fast-to-slow twitch fibre type shifts (Röckl et al., 2008). Activation of 
calcineurin, initiated by the binding of Ca2+ to the calmodulin-calcineurin complex, increases 
its phosphatase activity. The primary substrate of calcineurin is the nuclear factor of activated 
t cells (NFAT) transcription factors (Chin et al., 1998). Once dephosphorylated, NFAT 
translocates to the nucleus where it activates the “slow-fibre program” of genes (Chin et al., 
1998). Thus, Ca2+ itself is a potent stimulus for induction of fibre type shifts and changes in 
SERCA expression. However, other signals partially independent of significant perturbations 




Regulation of SERCA expression by thyroid hormone.   
Artificial induction of hypo- and hyperthyroidism has a profound influence on 
SERCA isoform expression, particularly SERCA1a. Early studies in a myogenic cell line 
developed from rat (L6) demonstrated that administration of 5 nM 3,5,3'-triiodo-L-thyronine 
(T3) resulted in an increase in SERCA1a protein by ~160% (Thelen et al., 1994). This study 
also found that SERCA1 mRNA was elevated by ~240%, suggesting that T3 can regulate 
SERCA1a at the genomic level. Studies examining the effects of thyroid status on rabbit 
soleus muscles indicate that hypothyroidism results in large reductions (50-80%) in 
SERCA1a protein and only a modest attenuation (~30%) of SERCA2a (Van Der Linden et 
al., 1996; Arruda et al., 2005). Conversely, hyperthyroidism can induce massive elevations in 
SERCA1a content (2-6 fold), and cause significant reductions in SERCA2a content ranging 
from 30-70% (Van Der Linden et al., 1996; Yamada et al., 2004; Arruda et al., 2005).  
The mechanisms associated with SERCA gene expression and thryoid status are 
complex and well documented (for review see; Simonides et al., 2001). T3 stimulated 
transcription of SERCA1 requires T3 binding to a T3-receptor (TR) (Simonides et al., 2001). 
The primary TRs in skeletal muscle are TRα1  and TRβ1. Once activated these receptors 
bind to the thyroid hormone response element on the SERCA1 gene and potentiate 
transcription. Interestingly, [Ca2+]f may influence the efficacy of T3-induced SERCA1a 
expression. Muller and colleauges (1992) showed that the stimulatory effect of T3 on 
SERCA1a expression at a [Ca2+]f of 120 nM was nearly abolished at 185 nM. Considering 
the rise in [Ca2+]f during CLFS, a suppression of the stimulatory effect of endogenous T3 may 





Post-translational regulation of SERCA. 
Post-translational regulation of SERCA is mediated by two small proteolipids, 
sarcolipin (SLN) and phospholamban (PLN), that are respectively, 31 and 52 amino acids in 
length (Wawrzynow et al., 1992; Fujii et al., 1987). The existence of SLN was first observed 
by MacLennan and co-workers (1972), who noted a protein with an apparent molecular mass 
of ~6 kDa that co-purified with the Ca2+-ATPase of rabbit skeletal muscle (Odermatt et al., 
1998). SLN and PLN possess similarity in their genes, which results in significant 
conservation of amino acid residues between the two proteins. Therefore, it has been 
proposed that the SLN and PLN genes are members of a family (Odermatt et al., 1997).  
Manipulation of thyroid status and chronic contractile activity can alter the gene 
expression of SLN and PLN. Studies have found that CLFS for only 3-7 days initiates 
transcription of both SERCA2a and PLN genes with an apparent decrease in transcription of 
the SERCA1a gene (Hu et al., 1998). However, a study by Odermatt and colleagues (1998) 
found that 3-4 days of CLFS caused no change in SERCA1a protein, but there was an ~40% 
decrease in SLN protein. In the heart, hypothyroidism attenuates SERCA2a content whereas 
hyperthyroidism increases SERCA2a protein (Kiss et al., 1994; Shenoy et al., 2001). The 
opposite is true for PLN. Hypo- and hyperthyroidism results in the increase and attenuation 
of PLN, respectively (Kiss et al., 1994; Holt et al., 1999; Shenoy et al., 2001). 
Until recently, attempts to develop an antibody for SLN have been unsuccessful 
(Vangheluwe et al., 2005). This has resulted in the majority of knowledge about SLN 
expression being derived from mRNA levels in tissue. However, what appears to be a viable 
SLN antibody (i.e. does not cross react with PLN) has been developed (Babu et al., 2007). As 




PLN expression is robust (Babu et al., 2007). The notion that SLN and PLN respectively, are 
expressed in fast- and slow-twitch skeletal muscle has been an oversimplification as SLN and 
PLN are co-expressed in the soleus of mouse, rat and rabbit (Babu et al., 2007). 
Characterizing the expression pattern of SLN and PLN in skeletal muscle is important from a 
structure-function perspective as their influence on SERCA is largely dependent on the ratio 
of SERCA to SLN and/or PLN (Mall et al., 2006).  
The structures of SLN and PLN are similar in their transmembrane regions. Each 
protein has a single transmembrane α-helix. This highly conserved region corresponds to 
amino acids 22-52 and 8-26 in PLN (domain II) and SLN, respectively (Sugita et al., 2006; 
Bhupathy et al., 2007). Disparity in the structure of SLN and PLN arises in the N- and C-
terminus regions. PLN exhibits a second α-helix (domain Ia) in the N-terminal sequence 
(amino acids 1-16) that physically interacts with SERCA2a (Tada & Toyofuku, 1996; Sugita 
et al., 2006). The cytoplasmic domain Ia of PLN is linked to the transmembrane domain II by 
a less structured, more flexible link (domain Ib) composed of 5 amino acids (Sugita et al., 
2006). Interaction between SLN and SERCA1a has been shown to occur with the highly 
conserved RSYQY lumenal domain of SLN and Phe73, Trp77, Ile85 and Phe88 of 
SERCA1a (Hughes et al., 2007). Furthermore, SLN’s RSYQY domain (C-terminus) appears 
vital for compartmentalization of SLN within the ER/SR membrane, as demonstrated in 
HEK-293 cells co-transfected with NF-SLN (N-terminally FLAG tagged SLN) and SERCA 
cDNAs (Gramolini et al., 2004). 
Through their interactions with SERCA, PLN and SLN decrease the apparent affinity 
of SERCA for Ca2+. Inhibition is alleviated when [Ca2+]f is elevated or through 




protein kinase A (PKA) and/or at Thr17 by Ca2+/Calmodulin-dependent protein kinase 
(CaMKII) reverses the inhibitory protein-protein interaction between PLN and SERCA2a 
(MacLennan et al., 2002; Morita et al., 2008). Recently, it was demonstrated that SLN may 
be phosphorylated in the hearts of mix bred NF-SLN transgenic and PLN knock-out mice 
(Gramolini et al., 2006). These authors found that SLN phosphorylation may occur at Ser4 or 
Thr5 via a Serine/Threonine Kinase 16. However, the ability of SLN to be phosphorylated 
within skeletal muscle has yet to be determined. 
Extensive work investigating the structure and function relationship between SLN, 
PLN and SERCA has been performed by David MacLennan’s group. They have utilized 
HEK-293 cells as a host to express these proteins and have performed a plethora of 
mutagenesis and cross-linking experiments to model specific interaction sites among these 
proteins (Traaseth et al., 2008). Structurally, PLN exists as inactive pentamers or as active 
monomers interacting with available SERCA molecules. Typical interactions between 
SERCA and PLN or SLN occur as heterodimers. However, when SLN, PLN and SERCA1a 
or SERCA2a are expressed together in HEK-293 cells, super inhibition of Ca2+-ATPase 
activity occurs (Odermatt et al., 1998; Asahi et al., 2002). Asahi and colleagues (2002) 
demonstrated that the presence of SLN increased the monomer:pentamer ratio (i.e. increased 
the number of active PLN molecules). Furthermore, SLN was found to physically interact 
with PLN and stabilize PLN binding to SERCA, which likely contributed to the super 
inhibition (Asahi et al., 2002). When SERCA1a is in the E2 conformation, PLN, SLN or both 
PLN-SLN can bind to SERCA1a in a groove formed by the transmembrane helices M2, M4, 
M6 and M9 (Morita et al., 2008; Asahi et al., 2003). Cross-linking studies demonstrate that 




SERCA1a; Gln23 on PLN and Lys328 on SERCA1a) (Toyoshima et al., 2003; Morita et al., 
2008). Once phosphorylated it is believed that salt bridges form between the Pi and amino 
acids Arg9, 13 and/or 14 of PLN, which alters the conformation within domain Ia of PLN 
and causes it to dissociate from SERCA (Sugita et al., 2006). 
At saturating Ca2+ concentrations, PLN does not influence the Vmax of SERCA2a. 
However, the effect SLN on the Vmax of SERCA1a remains somewhat contentious. An early 
study by Odermatt and colleagues (1998) found that NF-SLN co-transfected with SERCA1a 
into HEK-293 cells resulted in stimulation of Vmax. However, further investigation by the 
same group suggested that SLN did not significantly alter Vmax of SERCA1a (Asahi et al., 
2002). Furthermore, when SLN was reconstituted with SERCA1a in lipid, a decrease in Vmax 
of ~20% occurred (Hughes et al., 2007). It is evident that there are methodological 
implications for measuring Vmax of SERCA in the presence of SLN. It appears that the lipid 
environment and the ratio of SERCA:SLN are critical. Conceivably, SLN does not influence 
Vmax of SERCA1a, given the homology between PLN and SLN and the fact that PLN has no 
effect on SERCA Vmax.  
 
Oxidative stress and SERCA function. 
Oxidative stress caused by ageing, hyperthermia, ischemia-reperfusion (IR), certain 
disease states and exercise can modify SERCA post-translationally. Several studies have 
utilized heat stress and exercise as models of oxidative stress, in order to examine the effects 
on SERCA function. Indeed, exercise of various modalities has deleterious effects on SR 
Ca2+ handling in humans (Hill et al., 2001; Tupling et al., 2000; Leppik et al., 2004) and in 




study that utilized isometric contractions (Sahlin et al., 2006) and another that used eccentric 
contractions (Nielsen et al., 2005), failed to observe significant reductions in SR Ca2+-uptake. 
Moreover, repeated electrical stimulation of rat hind-limb and exercise have been shown to 
increase SERCA activity in muscles of low oxidative potential (Ferrington et al., 1996; 
Holloway et al., 2006). Explanations as to the mechanisms responsible for reduced Ca2+-
ATPase activity following exercise have ranged from alterations in ATP concentration (de 
Meis & Sorenson, 1989), glycogen (Lees et al., 2003) and changes in pH (Mandel et al., 
1982; Matsunaga et al., 2003). However, there is a growing body of evidence suggesting that 
reactive oxygen species (ROS) generated during exercise may contribute to the reductions in 
Ca2+-ATPase activity.  
Exercise potentiates the generation of ROS and reactive nitrogen species (RNS) in 
skeletal muscle. Kobzik and co-workers (1994) were the first to demonstrate that neuronal 
nitric oxide synthase (nNOS) is present in mammalian skeletal muscle. That study also 
demonstrated that nitric oxide (NO·) production and/or NO· intermediates accounted for 
~33% of the reducing equivalents generated in resting diaphragm whereas superoxide anion 
(O2·-) did not contribute significantly to the reduction of cytochrome c (Kobzik et al., 1994). 
However, during muscle contraction, O2·- was the predominant reducing equivalent 
contributing to the reduction of cytochrome c. O2·- can be dismutated enzymatically into 
hydrogen peroxide (H2O2) in the mitochondria and cytosol by manganese superoxide 
dismutase (Mn-SOD) and Cu/Zn-SOD, respectively. If Mn- and Cu/Zn-SOD fail to clear the 
cell of O2·- then it may react with other ROS/RNS, proteins or lipids. For example, the 
reaction of NO· and O2·- is extremely rapid, with a rate constant of l.9 ± 0.2 x 1010 M-1 · s-1 




SERCA1a and SERCA2a contain 24 and 26 cysteine (Cys) residues, respectively, 
making SERCAs highly susceptible to oxidative stress (Tupling et al., 2007). Numerous 
studies have characterized the effects of ROS on SERCA activity in vitro. An early study by 
Scherer and Deamer (1986) incubated SR fractions isolated from lobster and rabbit skeletal 
muscle with ammonium peroxydisulfate (APD) and found that SERCA activity was reduced 
by approximately 39%. This study also found that the sulfhydryl (SH) content of SR 
fractions incubated with APD was reduced significantly, as determined by the DTNB assay. 
Reductions in SERCA activity were not alleviated by incubation with anti-oxidants but 
incubation with strong reducing agents (dithiothreitol; DTT or mercaptoethanol) protected 
enzyme function (Scherer & Deamer, 1986). Consistent with the results from the study by 
Scherer and Deamer (1986), other studies have found that incubation of enriched SR with 
hypochlorus acid (Favero et al., 1998), FeSO4/EDTA (Kaplan et al., 2003) or diamide 
(Senisterra et al., 1997) reduced Ca2+-ATPase activity significantly, which was associated 
with reductions in free SH content. However, several studies have shown that ROS-induced 
inactivation of SERCAs can occur in the absence of SH oxidation (Castilho et al., 1996; 
Viner et al., 1997). Alternative mechanisms of inactivation include protein fragmentation 
and/or protein aggregation (Castilho et al., 1996;Viner et al., 1997).   
Protein aggregation could lead to the development of high molecular weight 
aggregates, which can be visualized by sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE) and Western blotting (Castilho et al., 1996). Evidence that 
SERCAs form aggregates suggests that multiple SERCAs form intermolecular bonds or that 
a single SERCA pump can cross-link with other SERCAs or smaller SERCA fragments. It 




responsible for the development of high molecular weight aggregates (Senisterra et al., 
1997). However, Viner and colleagues (1997) proposed that formation of RSSR bonds was 
not responsible for SERCA aggregation and suggested the likely mechanism was bityrosine 
formation. It appears that the assay conditions and the type of oxidant used may influence the 
mechanism by which inactivation of SERCA occurs. 
 A mechanism associated with reduced Ca2+-ATPase activity following ROS 
exposure that has gained support in recent years is damage to the N-domain of SERCA. The 
headpiece of SERCA requires a great deal of mobility in order to proceed through a reaction 
cycle, particularly in the N-domain. Therefore, if the N-domain is compromised structurally, 
the ability of ATP to bind to SERCA and phosphorylate Asp351 may be reduced, which 
would result in depressed ATPase activity. An elegant study by Xu and colleagues (1997) 
found that if SR vesicles were pre-incubated with 1 mM ATP for 3 min prior to exposure to 
hydroxyl radical (˙OH) that Ca2+-ATPase activity was fully protected. The authors suggested 
that ATP bound to SERCA protected crucial amino acids near Asp351 from oxidation, and 
that Cys349 is a likely candidate for protection (Xu et al., 1997). Indeed, the N-domain of 
SERCA1a contains 7 Cys residues (MacLennan et al., 1985) and is therefore a potential 
target of ROS induced oxidation. Furthermore, incubation of isolated SR with hypochlorus 
acid reduced fluorescein isothiocyanate (FITC) binding to SERCA in a concentration 
dependent manner (Favero et al., 1998). FITC is used as a marker of the structural integrity 
of the N-domain of SERCA, since FITC covalently binds to Lys515 on SERCA1a, which is 
in close proximity to the nucleotide binding site (Abu-Abed et al., 2002). However, FITC is a 
crude marker of structural alterations to SERCA and provides no detail of the specific amino 




Site specific modification to SERCA by ROS/RNS. 
The development of proteomic techniques by Christian Schöneich’s group has vastly 
improved the understanding of how ROS/RNS inhibit SERCA by identifying specific 
residues that are modified within the amino acid sequence of SERCA. In a study by Viner 
and colleagues (1999a), SERCA1a was exposed to varying concentrations of ONOO-, the 
amount of oxidized Cys residues was determined and the amino acid sequence of tryptic 
fragments were analyzed using an HPLC-MS system. They found a progressive decrease in 
the amount of reduced Cys residues with increasing concentrations of ONOO-. HPLC-MS 
analysis revealed that 100 μM ONOO- oxidized Cys614, 498, 525, 471, 344, 349 and based 
on their functional measures of SERCA1a ATPase activity and other experiments they 
confirmed the hypothesis of Xu and co-workers (1997), that reduced Cys349 is critical for 
proper enzyme function.  
In a similar study, SR fractions isolated from rabbit fast-twitch skeletal muscle were 
exposed to DEA/NO (a NO· donor) in vitro and the oxidation of Cys residues on SERCA1a 
was assessed (Viner et al., 2000). Incubation of SERCA1a with 0.1 mM DEA/NO lead to a 
greater number of Cys residues being oxidized when compared to their previous study, which 
utilized ONOO- (Viner et al., 1999a). In total, NO· oxidized 13 Cys residues on SERCA1a 
whereas ONOO- only oxidized 6 Cys residues. These authors suggested that the majority of 
Cys residues oxidized are not critical for enzyme activity and that they may represent 
“endogenous” antioxidants for the enzyme (Viner et al., 2000). This concept was echoed by 
Grover et al., (1997), who attributed the greater susceptibility of SERCA2b than SERCA3 to 
H2O2 induced inactivation as a result of differences in their Cys content. SERCA2b and 




not known how many Cys residues were oxidized on each SERCA isoform or whether 
critical Cys residues in SERCA2b and SERCA3 were compromised (Grover et al., 1997). 
Although SERCA isoforms have a high degree of sequence homology, these studies suggest 
that slight variations in amino acid sequence (i.e. number of Cys residues) and/or 3-D 
conformation may confer different levels of susceptibility to oxidative stress.  
The cardiac isoform of SERCA, namely SERCA2a, shares 84% homology with 
SERCA1a (Viner et al., 1999b), yet SERCA2a more readily undergoes nitration of tyrosine 
(Tyr) residues when compared to SERCA1a (Sharov et al., 2002). SERCA1a shares 16 out of 
the 18 Tyr residues of SERCA2a, yet only Tyr122 is nitrated on SERCA1a following 
exposure to ONOO- (Sharov et al., 2002). The effects of ageing on amino acid residues of 
SERCA1a have shown that Cys is preferentially oxidized, encompassing at least 10 Cys 
residues (Sharov et al., 2006). In young rat heart, SERCA2a contained 3-nitrotyrosine (3-
NY) residues at Tyr122, 130, 497, 586, 990 and as animals aged Tyr294, 295, 753 were 
further nitrated (Knyushko et al., 2005). Nitration of Tyr294 and Tyr295 appears to heavily 
influence the catalytic activity of SERCA2a as these amino acid residues are in close 
proximity to the Ca2+ binding sites (Knyushko et al., 2005). Taken together, these studies 
suggest there are critical amino acids that are altered by ageing (in vivo oxidative stress) or 
exogenous ROS/RNS (in vitro), which depends on the oxidant and the SERCA isoform in 
question.   
Regardless of the oxidant used, a common methodological approach to investigating 
the effects of ROS on SERCA function has been to incubate samples with a single bolus of 
ROS for a given period of time and then perform functional measurements. A novel study by 




compared to many smaller sequential additions of ONOO- on SR isolated from rabbit fast-
twitch skeletal muscle. In physiological conditions the half-life of ONOO- is <0.1 sec. 
Therefore, in the “chronic” condition the concentration of ONOO- would likely be 
maintained at a higher concentration when compared to the acute bolus condition. In both 
conditions the final concentration of ONOO- was identical, however, the reduction in 
SERCA1a activity was exacerbated in the chronic exposure condition (Gutiérrez-Martin et 
al., 2004). These authors attributed the reductions in Ca2+-ATPase activity to Tyr nitration 
and Cys oxidation, which is supported by their observation that epicatechin (blocker of 
tyrosine nitration) and glutathione (GSH) fully protected enzyme activity. However, no 
comparison between the degree of Cys oxidation and Tyr nitration were made between the 
acute and chronic ONOO- conditions. Therefore, further investigation into the mechanisms 
responsible for the potentiated reduction of Ca2+-ATPase activity in the chronic ONOO- 
condition is warranted.   
 
Protection of SERCA function from oxidative stress. 
Prevention or attenuation of ROS induced damage of SERCAs could have functional 
benefits in vivo (i.e. improve contractile function following an acute stress). The potential 
protective effects of anti-oxidants on SR Ca2+-ATPase activity exposed to ROS have been 
investigated in vitro (Moreau et al., 1998; Kaplan et al., 2003). The deleterious effects of 
FeSO4/EDTA on SERCA2a ATPase activity were almost completely reversed when pre-
incubated with either butylated hydroxytoluene (BHT; lipid soluble anti-oxidant) or 
glutathione (GSH; water soluble) (Kaplan et al., 2003). Another study observed that only 




(Favero et al., 1998). On the contrary, pre-incubation with BHT or DTT failed to protect 
SERCA activity following exposure to ˙OH (Moreau et al., 1998). It would appear that if the 
oxidative stress were too severe, then antioxidants and reducing agents could not prevent or 
reverse oxidative damage to SERCA and maintain proper enzyme function.  
 
Structure and function of heat shock protein 70. 
Eukaryotic cells possess an innate mechanism for protection against oxidative stress 
induced protein damage. Heat shock proteins (Hsps) are members of a highly conserved 
family of proteins that possess a variety of functions, but are best known for chaperoning and 
folding nascent peptides and re-folding partially denatured proteins (Welch, 1992; Liu et al., 
2006). Hsp70 and Hsp60 are localized respectively, in the cytosol and mitochondria, and are 
vital for proper folding and re-folding of proteins. The highly inducible form, Hsp70 is 
rapidly upregulated in cardiac and skeletal muscle following bouts of exercise (Milne & 
Noble, 2002), hyperthermia (Ruell et al., 2004) and mild IR (Trost et al., 1998). Elevation of 
Hsp70 in response to a mild stress can provide cyto-protection from subsequent potentially 
lethal stress, a phenomenon termed preconditioning (Yamashita et al., 1997).  
Human Hsp70 is a 640 amino acid cytosolic protein, which possesses two distinct 
domains (Sriram et al., 1997). The N-terminal domain is 388 amino acids in length (44 kDa) 
and is referred to as the nucleotide binding domain (NBD) (Sriram et al., 1997; Goloubinoff 
& De Los Rios, 2007). The C-terminal region is the 28 kDa substrate binding domain (SBD) 
(Goloubinoff & De Los Rios, 2007). This region can be further subdivided into the actual 18 





For efficient ATPase turnover and substrate folding, Hsp70 relies on several co-
chaperones. Hsp40 stimulates ATP hydrolysis by Hsp70 and aids in the targeting of 
substrates. The nucleotide exchange factors (NEFs) facilitate the release of ADP and the 
subsequent binding of an ATP molecule (Liu & Hendrickson, 2007). Recent evidence 
suggests that in eukaryotes the primary NEF that interacts with Hsp70 is Hsp110 (Lui & 
Hendrickson, 2007).  
The reaction cycle of Hsp70 begins with recognition of exposed hydrophobic residues 
on a target substrate, typically performed by Hsp40. However, assistance by Hsp40 is not 
required for Hsp70 interaction with target proteins. An ATP-Hsp70 complex will then bind to 
the target protein via several hydrophobic patches in the SBD. The γ-phosphate of ATP 
transferred to Hsp70, which causes a significant conformational change that “locks” Hsp70 
to the target protein, thus preventing initial or further aggregation (Goloubinoff & De Los 
Rios, 2007). The ADP-Hsp70 complex is considered the active state of Hsp70 and possesses 
high affinity for the substrate (Hendrickson & Liu, 2008). Hsp110 mediates the release of 
ADP from cytosolic Hsp70, which results in release of the substrate (Lui & Hendrickson, 
2007; Goloubinoff & De Los Rios, 2007). 
 
Protection of SERCA by Hsps. 
The mechanisms associated with Hsp70’s role in cyto-protection have yet to be fully 
elucidated. It has been demonstrated in yeast that overexpression of Hsp60 increased cell 
survivability and reduced protein oxidation after exposure to H2O2 (Cabiscol et al., 2002). 
Another study found that the prokaryote analog of Hsp60, GroEL was able to protect 




1999). An in vitro study in which isolated SR from rat fast-twitch skeletal muscle was 
incubated at 37oC or 41oC in the absence or presence of rat recombinant Hsp70, found that at 
37oC Hsp70 prevented thermal inactivation of SERCA1a (Tupling et al., 2004). The 
mechanism associated with Hsp70 protection of SERCA1a activity appeared to be related to 
preservation of the structural integrity of the N-domain, as indicated by FITC binding assays. 
Furthermore, 3-D modeling of SERCA1a and Hsp70 suggested that the likely binding region 
of Hsp70 is at or near the N-domain of SERCA1a.  
Recently, it has been demonstrated that co-expression of Hsp70 with SERCA2a in 
HEK-293 cells protected Ca2+-ATPase activity following exposure to thermal stress (Fu & 
Tupling, 2007). Similar to the study by Tupling and co-workers (2004), thermal inactivation 
of SERCA2a was associated with reduced FITC binding, which was prevented in the 
presence of Hsp70 overexpression (Fu & Tupling, unpublished results). In addition, Hsp70 
lowered the degree of oxidation of SERCA2a as demonstrated by a reduction in reactive 
carbonyl content. In both studies, co-immunoprecipitation assays demonstrated that Hsp70 
can physically interact with both SERCA1a (Tupling et al., 2004) and SERCA2a (Fu & 
Tupling, unpublished results). Taken together, Hsp70 appears to be a strong candidate for 
protection of SERCA1a and SERCA2a from in vitro and in vivo thermal stress.  
To date, studies have only examined the protective effects of Hsps on SERCAs 
following thermal stress. It should be noted that thermal stress in vivo increases ROS 
production. Indeed O2˙- production increases as a function of temperature from 37 to 45oC 
(Salo et al., 1991). Moreover, during muscle contraction, IR and certain diseases the 
generation of ROS/RNS are exacerbated (Kobzik et al., 1994; Zweier 1988; Ying et al., 




SERCA (Matsunaga et al., 2003; Tupling et al., 2001; Ying et al., 2008). Preconditioning 
enhances Hsp70 levels in the myocardium and protects contractile function and preserves SR 
Ca2+ handling (O’Brien et al., 1997). This suggests that Hsp70 may protect SERCA2a 
function during ischemia and the subsequent reperfusion (i.e. oxidative stress).  However, no 
study has examined the interaction between Hsp70 and SERCA2a using direct incubation 
with ROS/RNS. Therefore, it is important to characterize the isolated effects of ROS/RNS on 
the physical interaction between SERCA2a and Hsp70.  
 
Purpose. 
The purpose of this study is to determine the effects of ONOO- on SERCA2a 
structure and function in the presence and absence of Hsp70 overexpression. The major 
objectives are:  
(1) to determine if Hsp70 can prevent ONOO--induced inactivation of SERCA2a and  
(2) to determine the mechanisms associated with ONOO--induced inactivation of 
SERCA2a.  
(3) to determine the molecular mechanisms responsible for protection (or lack there 
of) of SERCA2a by Hsp70. 
HEK-293 cells co-transfected with SERCA2a and pMT2 (empty vector) or with 
SERCA2a and Hsp70 cDNAs were exposed to ONOO- chronically (multiple micro 
additions), similar to the methods of Gutiérrez-Martin et al. (2004). SERCA2a aggregation, 
FITC binding, reactive carbonyl content and tyrosine nitration were assessed using 
immunoprecipitation and Western blotting techniques to determine the mechanisms 






It was hypothesized that: 
(i) ONOO- would reduce Ca2+-ATPase activity of SERCA2a and that the 
overexpression of Hsp70 would fully protect activity. 
 
(ii) overexpression of Hsp70 would prevent 3-nitrotyrosine formation on SERCA2a 
following ONOO- exposure. 
 
(iii) ONOO- would cause a reduction in FITC binding to SERCA2a and 
overexpression of Hsp70 would protect the N-domain of SERCA2a and preserve 
FITC binding. 
 
(iv) ONOO- would increase reactive carbonyl content on SERCA2a, which would be 








 To synthesize ONOO-, isopentyl nitrite and 30% H2O2 were purchased from Sigma. 
The protein-G-sepharose used to immunoprecipitate SERCA2a was purchased from Sigma. 
Pyruvate kinase, NADH and the Complete® protease inhibitor were from Roche. The 
SERCA2a antibody was purchased from Affinity BioReagents; Anti-nitrotyrosine antibody 
was from Cayman Chemicals; Anti-Hsp70 was from Assay Designs; Anti-
fluoroscein/Oregon Green® was from Invitrogen; Anti-DNP was from Sigma and all 
secondary antibodies were from Santa Cruz. All other reagents were purchased from Bioshop 
Canada, Sigma or Fisher and were of analytical grade. 
 
Synthesis of ONOO-. 
ONOO- was synthesized similar to the protocol developed by Uppu & Pryor (1996). 
In an ice-water bath, 1.56 M H2O2, 1.56 M NaOH, 1.56 mM EDTA in at total volume of 6.94 
mL was mixed vigorously with a magnetic stir bar for 10 min. The mixture was removed 
from the ice-water bath, 5860 μL of 96% isopentyl nitrite was added to the solution, which 
brought the final volume to 12.8 mL and then the reaction was allowed to proceed at room 
temperature for 3 hours. Immediately after the 3 hr incubation, two post-processing steps 
were performed to remove contaminants. First, the mixture was washed 3 times with 2 
volumes of dichloromethane to remove any remaining isopentyl nitrite or isopentyl alcohol. 
Second, the solution was purged with N2 to remove any dissolved gases or trace organic 
solvents (Uppu, 2006). To determine the concentration of ONOO- produced, the ONOO- 




Coulter). The concentration of ONOO- was calculated using the extinction coefficient 
1670 M−1 · cm−1 and ranged from 235-270 mM. Aliquots of ONOO- were stored at -80oC and 
the concentration was calculated daily prior to use. 
 
Culture and Transfection of HEK-293 Cells.  
Human embryonic kidney cells (HEK-293) were cultured in DMEM-high glucose 
medium (HyClone) supplemented with 10% fetal bovine serum (Sigma), 1% 
penicillin/streptomycin (Sigma) and 2 mM L-Glutamine (HyClone) and housed in a 
humidified incubator at 37oC with 5% CO2. When HEK-293 cells neared confluence they 
were split at a ratio of 1:15 and transferred to 150 x 20 mm plates (Falcon). Twenty-four 
hours later the medium was aspirated and replaced with 18 mL of fresh media. Cells were 
then co-transfected with plasmids encoding rabbit SERCA2a (Brandl et al., 1986; Asahi et 
al., 1999)  in combination with the pMT2 vector (S2a-pMT2) or with human Hsp70 (S2a-
Hsp70) (Wu et al., 1985) using the Ca2+-phosphate precipitation method (Asahi et al., 1999; 
Kimura et al., 1998; Odermatt et al., 1998). Prior to experiments with ONOO-, the 
transfection ratio of SERCA2a and Hsp70 cDNA was determined such that the expression of 
SERCA2a was optimized (3 μg : 1 μg). 
 
Experimental Design.  
On a given day, cells were split into two groups and co-transfected with S2a-pMT2 or 
S2a-Hsp70. Seventy-two hours after co-transfection, each group was subdivided such that 
half the S2a-pMT2 and S2a-Hsp70 served as controls (i.e. were not exposed to ONOO-) and 




created (i.e. Control S2a-pMT2, S2a-Hsp70 and ONOO- S2a-pMT2, S2a-Hsp70). In the 
ONOO- groups, repeated micro volumes of ONOO- were added directly to cells in culture. 
During chronic exposure to ONOO- a total of 10 pulses of 250 μM ONOO- was added each 
min for a total incubation time of 10 min. The final concentration of ONOO- in culture was 
2.5 mM. To account for changes in pH due to the basic solution used to stabilize ONOO-, 
periodic additions of a 1M stock solution of HEPES were added to maintain the pH in a 
range of 7.2-7.6. The effect of ONOO- on the pH of the media was determined prior to work 
with cultured cells using a 3-point calibrated pH meter (Fisher) by adding ONOO- to 
complete media and monitoring the changes in pH. The volume of 1M HEPES required to 
maintain the pH in the 7.2-7.6 range was then determined and did not exceed 25 mM in 
culture.  
 
Isolation of the microsomal fraction. 
 Immediately following exposure to ONOO- the culture medium was removed from all 
groups and the cells were resuspended in ~24 mL of 1X phosphate buffered saline (PBS) 
with 5 mM EDTA. Cells were centrifuged for 5 min at 1300 g (SA 600 Rotor, Sorvall) and 
washed twice with 5 mL of ice-cold homogenizing buffer containing 250 mM sucrose, 5 mM 
HEPES, pH 7.5, 10 mM NaN3, and 0.2 mM PMSF. The final pellet was homogenized in 
1500 µL of homogenizing buffer using a handheld glass homogenizer (Duall 20, Kontes). 
Next, homogenates were sonicated (Vibra Cell, Sonics & Materials) for a total of 20 sec with 
a duty cycle of 2 sec on and 5 sec off at 60% intensity. A small aliquot of homogenate was 
flash frozen in liquid nitrogen for determination of Hsp70 expression in the S2a-pMT2 and 




Briefly, the homogenate was centrifuged at 9265 g for 30 min (SA 600, Sorval) to remove 
the heavy membrane fraction. The supernatant was transferred to clean tubes and spun at 
171500 g for 60 min (70.1 Ti Rotor, Beckman). The resulting pellet was resuspended in 400 
µL homogenizing buffer, aliquots were flash frozen in liquid nitrogen and stored at -70oC 
until subsequent analysis. 
 
Ca2+- dependent Ca2+-ATPase activity.  
Measurements of Ca2+-dependent Ca2+-ATPase activity were made at 37oC using a 
spectrophotometric assay developed by Simonides and Van Hardeveld (1990) adapted to a 
96-well plate reader (Duhamel et al., 2007). The assay buffer contained (in mM) 20 HEPES, 
pH 7.0, 100 KCl, 10 MgC12, 1 EGTA, 10 NaN3, and 10 PEP. For each sample, a cocktail 
containing 5 mM ATP, 18 U/mL LDH, 18 U/mL PK, 1 µM Ca2+ ionophore A23187, 200 μL 
microsomes and 3.6 mL assay buffer was combined in a test tube on ice. The cocktail was 
then subdivided (300 µL) into 16 microcentrifuge tubes with varying concentrations of 
CaCl2. The [Ca2+]f corresponding to each CaCl2 addition was assessed separately, on 
different microsome aliquots, by use of dual-wavelength spectrofluorometry and the Ca2+-
fluorescent dye Indo-1. The range of calcium additions translates into a pCa range of ~7.0-
5.0. Next, two 100 µL aliquots from each of the sixteen 300 µL subdivisions were loaded 
onto a clear bottom 96-well plate. The final step was the addition of ~2 µL of 33 mM NADH 
to each well. ATPase activity represents the decrease in NADH absorbance at 340 nm 
(SPECTRAmax Plus, Molecular Devices). To distinguish Ca2+-ATPase activity from 
background ATPase activity, 240 μM of the specific SERCA inhibitor, cyclopiazonic acid 




activity (activity in the presence of CPA) represented the Ca2+-ATPase activity. The reaction 
proceeded for 60 min at 37oC and the rate of decline in NADH absorbance was recorded 
approximately half way through the incubation period when the signals were linear (R2 > 
0.9). All values were normalized to total protein concentration and SERCA2a expression as 
determined by the Lowry assay and Western blotting, respectively. The Vmax was taken as the 
peak rate of activity, which typically occurred between a pCa of 5.5-5.0. 
 
Western blot analysis.  
Western blotting was performed to determine the relative expression levels of 
SERCA2a and Hsp70 in microsomes and homogenate prepared from S2a-pMT2 and S2a-
Hsp70. The linearity of band density was determined for each transfected batch of cells. For 
SERCA2a and Hsp70 respectively, a total of 4 and 0.33 µg of total protein was loaded on 
7.5% polyacrylamide gels and separated using standard SDS-PAGE protocols (Laemmli, 
1970). The gels were cut where appropriate and the proteins were transferred to a 
polyvinyldiene difluoride (PVDF) membrane (Bio-Rad) and blocked for 1 hr at room 
temperature with 10% milk in Tris-buffered saline plus Tween (TBS-T; Tris-HCl, pH 7.5, 
150 mM NaCl, 0.1% Tween 20). After blocking, antibodies for SERCA2a (1:4000; MA3-
919, Affinity BioReagents) and Hsp70 (1:1000; SPA-810, Assay Designs) were applied for 1 
hr at room temperature and overnight at 4oC, respectively. Subsequently, membranes were 
washed with TBS-T for 30 min and probed for 1 hr with horse-radish peroxidase conjugated 
anti-mouse secondary antibody (1:2000, Santa Cruz). After washing with TBS-T, the images 
were visualized using an enhanced chemiluminescent kit (GE Healthcare) and a bio-imaging 




respectively (Syngene). The group which contained the highest SERCA2a content (i.e. 
largest optical density) was assigned a value of 1 and the optical densities from the other 3 
groups were normalized to that optical density. These correction factor for SERCA2a content 
were then used to normalize Vmax, FITC binding, 3-nitrotyrosine and reactive carbonyl 
content. 
In a subset of Western blots, SERCA2a content was determined in the absence of 2-
mercaptoethanol (i.e. under non-reducing conditions). Under these conditions it is presumed 
that RSSR bonds formed during treatment with ROS/RNS remain intact. Therefore, any 
protein aggregates will not migrate as far as the monomer band during SDS-PAGE. These 
aggregate proteins will appear as higher molecular weight bands in the Western blot. 
Microsomes from S2a-pMT2 and S2a-Hsp70 were blotted for SERCA2a under non-reducing 
conditions and then normalized to SERCA2a content from blots performed under reducing 
conditions. 
 
Co-immunoprecipitation of SERCA2a and Hsp70.  
To determine if ONOO- can induce Hsp70 binding to SERCA2a, co-
immunoprecipitation of SERCA2a using anti-hsp70 antibody (SPA-810; Assay Designs) was 
performed. Microsomes were diluted to 0.5 mg/mL with H2O, homogenizing buffer and 2X 
co-IP buffer (40 mM HEPES, pH 7.5, 300mM NaCl, 2mM EDTA, 10 mM MgCl2, 4 mM 
PMSF and 1% Tween). The solution was vortexed and centrifuged for 30 min at 16000 g 
(F2402 Rotor, Beckman GS-15R). The supernatant was transferred to new tubes, combined 
with 30 μL of a 50% slurry of protein-G-sepharose (v/v in 1X PBS containing 0.1% BSA & 




supernatants were transferred to new tubes. Next, 1.75 μL of 10% BSA and 1 μg of anti-
Hsp70 antibody were added to each tube and the samples were allowed to mix for 55 min at 
4oC. The samples were then spun at 12868 g for 10 min and the supernatants were placed in 
new tubes. Again, 30 μL of the protein-G-sepharose slurry were added to each sample and 
rotated for 30 min at 4oC. At this point the slurry was pelleted and the supernatant was 
discarded. The remaining protein-G-sepharose-antibody complex was washed 3 times with 1 
mL of 1X co-IP buffer and once with wash buffer (25 mM Tris pH 7.2, 150 mM NaCl). 
Samples were eluted with 36 μL of elution buffer (100 mM Glycine, pH 2.8) for 15 min on 
ice. Next, the slurry was pelleted and the supernatant was placed in a new tube containing 2 
μL of 1 M Tris, pH 9.0. Finally, 9 μL of 5X sample buffer (123.8 mM Tris pH 6.8, 10% 
SDS, 50% glycerol, 0.25% bromophenol blue & 25% 2-mercaptoethanol) were added to all 
samples, which were then separated using SDS-PAGE and probed via Western blotting using 
anti-SERCA2a antibody. 
 
Isolation of SERCA2a from the microsomes by immunoprecipitation (IP). 
 It was necessary to immunoprecipitate SERCA2a from the microsomal fraction in 
order to measure 3-NY content, FITC binding capacity and reactive carbonyl content of 
SERCA2a. This protocol was followed because in HEK-293 cells there is a large abundance 
of the Na+/K+-ATPase. The Ca2+-ATPase and the Na+/K+-ATPase are members of the P-type 
transporter family and are of similar size (~100 kDa) and 3-D structure (Morth et al., 2007; 
Toyoshima, 2000). Therefore, it would be impossible to discern the Ca2+-ATPase band from 
the Na+/K+-ATPase band when blotting for 3-NY content, FITC or reactive carbonyl content. 




SERCA2a, which improves the ability to a) detect 3-NY, FITC and reactive carbonyls and to 
b) detect differences between groups. Therefore, for each of these protocols (i.e. 3-NY 
content, FITC, carbonyl), SERCA2a was first immunoprecipitated from the microsomes.   
 
SERCA2a nitrotyrosine content.  
The degree of nitrosylation of SERCA2a was determined using the methods of Li et 
al. (2006) with slight modifications. Microsomes (1 mg/mL) were diluted with homogenizing 
buffer, H2O and 2X IP buffer (20 mM Tris, pH 7.4, 600 mM Sucrose, 1% CHAPS & 1 
protease inhibitor tablet; Complete© Roche) and mixed gently by inversion. The samples 
were then centrifuged for 10 min at 6000 g at 4oC. The supernatants were transferred to new 
tubes and 4 μL of 50% BSA and 1 μg of anti-SERCA2a antibody were added to each tube. 
The samples were allowed to mix overnight at 4oC. The next morning 5 μL of a 50% protein-
G-sepharose slurry was added to each sample and rotated at 4oC for 2 hrs. The protein-G-
sepharose was then centrifuged and the supernatant was discarded. The sepharose beads were 
then washed 3 times with 1X IP buffer. After washing, 10 μL of 2X sample buffer was added 
to each tube. Subsequently, 2 μL of each sample was loaded onto a 7.5% polyacrylamide gel 
in duplicate and separated by standard SDS-PAGE protocols. The membrane was probed 
with a monoclonal primary antibody specific for nitrotyrosine residues (1:1500, Cayman 
Chemicals). After washing with TBS-T the membrane was incubated with goat anti-mouse 
secondary antibodies (1:2000, Santa Cruz) and visualized using an ECL kit (GE HealthCare). 
The duplicate sample was probed for SERCA2a content using anti-SERCA2a antibody and 





Fluoroscein isothiocyanate binding capacity.  
FITC binding to SERCA2a was assessed on microsomes isolated from all groups of 
cells. In this instance SERCA2a was IP using a non-denaturing lysis buffer. This was 
important because it preserved the tertiary structure of SERCA2a. After washing, samples 
were eluted on ice for 15 min with 15 μL of elution buffer. Subsequently, 5 μL of 1.0 M Tris 
pH 9.0 was added to each sample and the sepharose was mixed thoroughly. Immediate 
neutralization of the sample was critical because this ensured that the 3-D structure and more 
specifically the N-domain of SERCA2a was not altered by the acidic pH of the elution 
buffer. After neutralization, the sepharose beads were centrifuged and 10 μL of the 
supernatant were combined with 80 μL of FITC binding buffer (50 mM Tris-HCl, pH 8.8, 
250 mM sucrose, 0.1 mM CaCl2, 5 mM MgCl2, 20 μM FITC & protease inhibitors) and 
incubated at room temperature in the dark for 1 hour. To stop the reaction, 20 μL of 5X 
sample buffer were added to each sample. Next, 10 μL of each sample were loaded on a 
7.5% polyacrylamide gel and separated by SDS-PAGE. The membranes were probed with 
anti-fluoroscein/Oregon Green® monoclonal antibody (4-4-20, Invitrogen) diluted 1:5000 in 
5% milk in TBS-T. Lastly, the membranes were probed with the appropriate secondary 
antibodies and the images were developed using GeneSnap (Syngene). The optical density 
was normalized to the content of SERCA2a in each group. 
 
SERCA2a reactive carbonyl content.  
Oxidation of SERCA2a protein was assessed by measuring the reactive carbonyl 
content of SERCA2a that had been immunoprecipitated from microsomes derived from cells 




to that used for nitrotyrosine determination. After washing the sepharose beads, samples were 
solubilized by adding 10 μL of 5% SDS to each tube. At this point 9 μL of the solution was 
removed, combined with 9 μL of 2X sample buffer and used for determination of SERCA2a 
content via Western blotting. Next, 12 μL of 10 mM 2,4-dinitrophenylhydrazine (DNPH) in 
2 M HCl was added to the remaining sample, which were then incubated at room temperature 
for 15 min. Immediately after incubation with 2,4-DNPH, 12 μL of neutralization buffer (2 
M Tris & 30% glycerol) were added to each tube, which were then placed back on ice. 
Subsequently, 18 μL of 2X sample buffer was added to each tube. Finally, 30 μL of 4X 
stacking buffer were added to each tube. The samples were centrifuged for 2 min and 10 μL 
of the supernatant were applied to a 7.5% gel and separated by SDS-PAGE. The proteins 
were transferred to a PVDF membrane and blocked over night with 10% BSA in TBS-T. 
After washing with TBS-T for ~10 min, the membrane was incubated for 1 hr at room 
temperature with a mouse monoclonal antibody specific for DNP (SPE-7, Sigma) that was 
diluted 1:20000 in TBS-T supplemented with 0.2% BSA. After washing, the membrane was 
probed with an anti-mouse secondary antibody (Santa Cruz) diluted 1:5000 and the signal 
was visualized using an ECL Plus kit (GE Healthcare) and the GeneSnap software package. 
 
Data Analysis. 
 Data presented below was collected from three independent experiments and are 
expressed as means ± standard error of the mean (SE). When an identical trend (i.e. increase 







Overexpression of Hsp70 in HEK-293 cells. 
 To optimize the expression of SERCA2a in HEK-293 cells co-transfected with 
SERCA2a and Hsp70 cDNAs, a transfection ratio of 3 µg SERCA2a cDNA:1 µg Hsp70 
cDNA was utilized. This transfection ratio resulted in a ~1.9-fold increase in the expression 
of Hsp70 in the S2a-Hsp70 cells when compared to endogenous Hsp70 present in S2a-pMT2 
cells (Figure 3).  
 
Ca2+-dependent Ca2+-ATPase activity. 
 The Ca2+ dependence of Ca2+-ATPase activity was determined in microsomes 
collected from control or ONOO- treated HEK-293 cells co-transfected with S2a-pMT2 or 
S2a-Hsp70. Figure 4 illustrates the maximal enzyme activity among each group. Co-
transfection of SERCA2a and Hsp70 cDNAs had no effect on Vmax when compared to 
SERCA2a alone (Figure 4, left panel). Repeated additions of 250 µM ONOO- resulted in a 
~20% reduction in Vmax in the S2a-pMT2 group when compared to the control S2a-pMT2 
group. However, overexpression of Hsp70 in HEK-293 cells fully protected against ONOO--






































Figure 3: Expression of Hsp70 in S2a-pMT2 and S2a-Hsp70 co-transfected HEK-293 
cells. (A) Representative Western blot of Hsp70 protein. Whole cell lysates were separated 
by SDS-PAGE and Western blotting was performed with a monoclonal antibody for Hsp70 
(SPA-810, Assay Designs). The left lane is the molecular weight standard (Western CTM, 
BioRad). 12.5 ng of recombinant rat Hsp70 protein were used as a positive control (2nd lane, 












Figure 4: Maximal Ca2+-ATPase activity of SERCA2a. HEK-293 cells were co-
transfected with S2a-pMT2 or S2a-Hsp70 cDNAs. Control samples were harvested in the 
absence of ONOO-. Cells were exposed to micro additions of ONOO- for a total of 10 min 
resulting in a final ONOO- concentration of 2.5 mM (see “Methods” for details). Values are 












































 Once it was determined that overexpression of Hsp70 could protect SERCA2a 
activity from exposure to ONOO-, it was then necessary to establish whether Hsp70 could 
physically interact with SERCA2a. To do this, co-immunoprecipitation experiments were 
performed using microsomes from control and ONOO- treated cells. Figure 5A depicts a 
representative Western blot using monoclonal antibodies against SERCA2a. It is evident that 
Hsp70 and SERCA2a physically interact under all conditions. The Western blot in Figure 5B 
confirms that Hsp70 was successfully immunoprecipitated by its monoclonal antibody.  
 
Immunoprecipitation and Western blot results. 
 To determine the mechanisms responsible for Hsp70 protecting SERCA2a activity 
from nitrosative stress, IP and Western blotting techniques were used to measure FITC 
binding, 3-nitrotyrosine and reactive carbonyl content as well as aggregation of SERCA2a. 
 
SERCA2a aggregation. 
Representative Western blots of SERCA2a from identical groups performed under 
reducing and non-reducing conditions are shown in Figure 6. Non-reducing Western blots 
(i.e. absence of 2-mercaptoethanol) were used to detect the presence of high molecular 
weight aggregates that formed during ONOO- treatment. Figure 6C is a graphical 
representation of the optical densities of the distinct (Figure 6B; white arrow) high molecular 
weight aggregates normalized to SERCA2a content under reducing conditions. In control 
cells, overexpression of Hsp70 resulted in a ~44% reduction in the appearance of SERCA2a 
aggregates, which had no influence on Vmax of SERCA2a. Treatment with ONOO- resulted in 




S2a-pMT2 group. When compared to the control S2a-pMT2 group, ONOO- increased 
aggregation by ~30% in the S2a-Hsp70 group. However, SERCA2a aggregation was still 
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Figure 5: Co-immunoprecipitation of SERCA2a and Hsp70. Microsomes from control 
and ONOO- treated HEK-293 cells were used for co-immunoprecipitation using a 
monoclonal antibody for Hsp70 (SPA-810, Assay Designs) as described under “Methods”. 
(A) The presence of SERCA2a bound to Hsp70 was determined via Western blotting using a 
monoclonal antibody for SERCA2a (MA3-919, Affinity BioReagents). (B) Detection of 
Hsp70 in the immuno-complex was also performed by Western blotting using the Hsp70 





Figure 6: Western blot analysis of SERCA2a high molecular weight aggregates. (A) 
Representative blot of SERCA2a under reducing conditions. The loading sequence is 
indicated with the appropriate labels. (B) Representative blot of SERCA2a under non-
reducing conditions. The white arrow indicates high molecular weight aggregates of 
SERCA2a. (C) Graphical representation of the optical density of the high molecular weight 






In order to isolate SERCA2a from the microsomal fraction, IP was performed. Once 
isolated, the extent of nitrosylation on SERCA2a was determined using an antibody specific 
for 3-NY residues. Western blot analysis revealed no differences between control S2a-pMT2 
and S2a-Hsp70 groups when normalized to SERCA2a content (Figure 7). Contrary to the 
initial hypothesis, treatment with ONOO- did not alter 3-NY content on SERCA2a in the 
S2a-pMT2 or S2a-Hsp70 groups. 
  
FITC binding capacity of SERCA2a. 
To assess FITC binding capacity of SERCA2a, IP was performed under non-
denaturing conditions. Figure 8 indicates that FITC binding was not different between the 
control S2a-pMT2 and S2a-Hsp70 groups when normalized to SERCA2a content. 
Unexpectedly, no change in FITC binding capacity of SERCA2a was observed in any group 
following ONOO- treatment. 
 
Reactive carbonyl content on SERCA2a. 
 Lastly, IP and Western blotting were utilized to determine changes in reactive 
carbonyl content (a measure of protein oxidation) on SERCA2a following exposure to 
ONOO-. An example of a typical Western blot of reactive carbonyl groups is illustrated in 
Figure 9A. Upon further examination of optical density (normalized to SERCA2a content), 
no differences in reactive carbonyl content were observed in the control groups (Figure 9B). 




ONOO- treatment. Overexpression of Hsp70 completely prevented the oxidation of 
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Figure 7: 3-nitrotyrosine levels on SERCA2a. SERCA2a was immunoprecipitated from 
Control and ONOO- treated microsomes from S2a-pMT2 and S2a-Hsp70 co-transfected 
HEK-293 cells as described under “Methods”. (A) A representative Western blot of 3-NY 
content on SERCA2a using a monoclonal antibody specific for 3-NY residues (Cayman 
Chemicals). (B) Graph of the optical density of Western blots for 3-nitrotyrosine content on 









































Figure 8: FITC binding capacity of SERCA2a. SERCA2a was immunoprecipitated from 
Control and ONOO- treated microsomes from S2a-pMT2 and S2a-Hsp70 co-transfected 
HEK-293 cells and probed with FITC as described under “Methods”. (A) A representative 
Western blot of FITC bound to SERCA2a determined via an anti-fluoroscein monoclonal 
antibody (4-4-20, Invitrogen). (B) The optical density of FITC binding to SERCA2a was 
















































Figure 9: Reactive carbonyl content on SERCA2a. SERCA2a was immunoprecipitated 
from microsomes and probed for reactive carbonyl groups as outlined in “Methods”. (A) A 
representative Western blot probed with monoclonal anti-DNP (Sigma). (B) A graph of the 
optical density of reactive carbonyls normalized to SERCA2a content determined separately 
on a different gel (n=3). 





Overexpression of Hsp70. 
This study utilized HEK-293 cells as a vessel for the overexpression of SERCA2a 
and Hsp70 in order to determine whether Hsp70 can protect SERCA2a structure and function 
from exposure to ONOO-. Co-transfection with S2a-Hsp70 cDNAs resulted in a ~1.9-fold 
increase in the Hsp70 protein in whole cell lysates when compared to S2a-pMT2 cell lysates. 
This level of Hsp70 overexpression is similar in magnitude with previous studies in humans 
and rodents that utilized various modalities to induce a stress response. A study by Milne and 
Noble (2002), demonstrated that treadmill running (33 m/min for 1 h) in rats resulted in a  
~5-, 2.5- and 6-fold increase in Hsp70 protein in cardiac, red vastus and white vastus 
muscles, respectively. In the absence of contractile activity, simply raising the core 
temperature of rats to 42oC for 15 min increased the Hsp70 content in cardiac muscle by 
~35% (Ruell et al., 2004). A recent study that used exercise as a mode to induce Hsp70 found 
that 30 min of intermittent isometric knee extension exercise resulted in ~40% increase in 
Hsp70 protein (Tupling et al., 2007). Other human studies that have utilized exercise to 
induce Hsp70 have found increases in Hsp70 protein ranging from ~170-3000% (Khassaf et 
al., 2001; Thompson et al., 2001; Thompson et al., 2003; Morton et al., 2006). It is evident 
that the ~1.9-fold overexpression of Hsp70 measured in this study is well within the 




Influence of ONOO- and Hsp70 on SERCA2a activity. 
 Incubation of S2a-pMT2 HEK-293 cells with 2.5 mM ONOO- resulted in a ~20% 
reduction in Vmax. These results are in agreement with the hypothesis that incubation with 
ONOO- would reduce SERCA2a activity. Numerous in vitro studies have examined the 
effects of ROS/RNS on SERCA function. Incubation of enriched SR fractions with either 
NO·, ·OH, HOCl, FeSO4/EDTA, H2O2 or ONOO- had detrimental effects on the ATPase 
activity of SERCA (Kaplan et al., 2003; Ishii et al., 1998; Xu et al., 1997; Favero et al., 1998; 
Grover et al., 1992; Gutiérrez-Martin et al., 2004). A study by Viner and co-workers (1999b) 
compared the effects of ONOO- on enriched SR from young rat fast- and slow-twitch 
muscles. This study demonstrated that incubation with 100 µM ONOO- decreased Ca2+-
ATPase activity in fast and slow SR by ~30 and 13%, respectively (Viner et al., 1999b). The 
differences in susceptibility of SERCA1a and SERCA2a to ONOO- were ascribed to 
differences in the degree of Tyr and Cys modification on each isoform. It appears as though 
specific ROS/RNS (i.e. ONOO-) can interact with SERCA1a or SERCA2a in very distinct 
ways. Incubation of SERCA1a with ONOO- only results in significant nitrosylation of 
Tyr122 (Sharov et al., 2002). Conversely, Tyr753, Tyr294 and Tyr295 are readily nitrated on 
SERCA2a following exposure to ONOO- (Knyushko et al., 2005). With ageing, SERCA2a is 
preferentially nitrosylated, whereas SERCA1a undergoes primarily Cys oxidation (Knyushko 
et al., 2005; Sharov et al., 2006). Further isoform differences were noted by Grover and 
colleagues (1997), who observed that the inactivation of SERCA2b caused by H2O2 was 
greater than the H2O2-induced inactivation of SERCA3. These authors attributed this to the 
fact that the amino acid sequence of SERCA2b contains 4 more Cys residues when compared 




A study found that when SR from fast-twitch skeletal muscle was exposed 
chronically to ONOO- (final [ONOO-]: 250 µM) that Ca2+-ATPase activity was reduced by 
~80% (Gutiérrez-Martin et al., 2004). Interestingly, when an acute bolus of 250 µM ONOO- 
was combined with enriched SR, Ca2+-ATPase activity was only reduced by ~50%. The large 
discrepancy in reduction in Ca2+-ATPase activity in the current study (~20%) compared to 
that of Gutiérrez-Martin and co-workers (2004) (~80%) is likely due to differences in 
SERCA isoform and methodological differences. Studies by Gutiérrez-Martin and co-
workers (2004) and Sharov and others (2006) observed large decreases in enzyme activity 
when SERCA1a was incubated with ONOO-. The current study utilized a ONOO- 
concentration ten times stronger than that of Gutiérrez-Martin et al. (2004). It may seem 
puzzling that the reduction in activity was a modest 20%. However, it should be noted that 
the incubation time in this thesis was short (10 min) when compared to Gutiérrez-Martin and 
co-workers (2004), which was upwards of 50 minutes. Furthermore, cells were incubated in 
culture with ONOO- versus in vitro incubation (Gutiérrez-Martin et al., 2004). When 
ROS/RNS are incubated with SR fractions in vitro the molarity of ROS/RNS added to the 
assay buffer is the concentration that interacts with SERCA. However, it is likely that the 
actual concentration of ONOO- that reached the ER membrane within the HEK-293 cells, 
and thus interacted with SERCA2a, was far less than the micro bolus of 250 µM added each 
minute. This is because ONOO- would have needed to first diffuse throughout the culture 
media, cross the plasma membrane and then diffuse within the cytosol to the site of 
SERCA2a expression. In addition, the degradation of ONOO- occurs rapidly at physiological 
temperatures, which further limits ONOO- ability to react with SERCA2a at the ER 




concentration that reacted with SERCA2a was far less than that added to the culture dish, 
which most likely explains the modest (~20%) reduction in SERCA2a activity. A similar 
reduction in SERCA2a activity of 13% was found following incubation of enriched SR from 
slow-twitch skeletal muscle with 100 μM ONOO- (Viner et al., 1999b). Perhaps the 
concentration of ONOO- that reacted with SERCA2a in the present study was closer in 
magnitude to that used in the study by Viner and co-workers (1999b). Regardless, this study 
demonstrates that incubation of cells in culture with ONOO- can inactivate proteins within 
those cells. 
The overexpression of Hsp70 in the present study had no effect on the Vmax of 
SERCA2a under control conditions. The most novel and exciting finding in the current study 
was that physiological overexpression of Hsp70 fully protected SERCA2a function from 
exposure to ONOO-. Numerous studies have shown that anti-oxidants or reducing agents 
may fully or partially protect SERCA function. However, this is the first study to 
demonstrate that a molecular chaperone, Hsp70, can protect SERCA2a activity in living cells 
that are exposed to exogenous ONOO-. In fact, only a handful of studies have been published 
that examined the interaction between Hsp70 and SERCA. An in vitro study by Javed and 
co-workers (1999) found that the prokaryote analog of Hsp60, GroEL, protected SERCA1a 
from thermal inactivation by preventing protein aggregation. More recently, it was 
demonstrated that when enriched SR membranes isolated from rat fast-twitch skeletal muscle 
were incubated at 37oC for 30 min that there was a ~20% reduction in SERCA1a Vmax 
(Tupling et al., 2004). However, when recombinant rat Hsp70 was added to the enriched SR 
fraction under identical heat stress conditions, Vmax of SERCA1a was fully protected. These 




incubation with ONOO- also reduced Ca2+-ATPase activity by ~20%. However, 
overexpression of Hsp70 fully protected SERCA2a from ONOO--induced inactivation. 
Interestingly, in the study by Tupling et al. (2004), when thermal stress was prolonged (i.e. 
>60 min) or samples were incubated at 41oC, Hsp70 was not able to protect SERCA1a 
function. There appears to be a limit to the extent to which Hsp70 can protect SERCA1a 
from heat stress (Tupling et al., 2004). Perhaps, if the ONOO- concentration or incubation 
time were increased then a further reduction in SERCA2a activity would occur. Given the 
similar magnitude of inactivation of SERCA in the current study and in the study by Tupling 
and colleagues (2004), there is likely a threshold where Hsp70’s ability to protect SERCA2a 
from ONOO--induced inactivation is abolished. Therefore, further investigation into the 
ability of Hsp70 to protect against severe oxidative stress is warranted. 
Further adding to the knowledge of SERCA and Hsp70 interaction is a study by Fu & 
Tupling (2007) that co-transfected HEK-293 cells with S2a-pMT2 and S2a-Hsp70 and then 
subjected the cells to heat stress. In the S2a-pMT2 cells, heat shock at 40oC for 1 h resulted 
in a ~60% reduction in Vmax of SERCA2a. However, Vmax of SERCA2a was fully protected 
in S2a-Hsp70 cells. In the study by Fu & Tupling (2007), inactivation of SERCA2a may 
have been the result of direct attack by ROS/RNS, thermal denaturation or both. In that study 
the production of ROS/RNS during heat stress was not assessed. The elevated temperature 
(40oC) would likely have resulted in an increased production of O2.- (Salo et al., 1991). Both 
Tupling et al. (2004) and Fu & Tupling (unpublished results) found that thermal stress 
reduced FITC binding to SERCA consistent with observations from several other studies (Xu 
et al., 1997; Favero et al., 1998). However, the current study failed to observe any changes in 




of SERCA2a in the current study compared to the studies by Tupling et al. (2004) and Fu & 
Tupling (unpublished results). This highlights the importance of characterizing the effects of 
specific ROS and RNS on the interaction between Hsp70 and SERCA2a.  
 
Immunoprecipitation of SERCA2a.  
To determine the amount of 3-NY, FITC binding and reactive carbonyls on 
SERCA2a, it was necessary to immunoprecipitate SERCA2a from the mircosomal fraction. 
This was an important step because SERCA2a was transfected into HEK-293 cells. Not 
surprisingly, these kidney cells contain significant amounts of the α1-subunit of the Na+/K+-
ATPase. The Ca2+-ATPase and the Na+/K+-ATPase are members of the P-type pump family 
and share functional and structural similarities. Both pumps bind their respective cations 
within their transmembrane domains and harness the energy from aspartylphosphate 
formation to transport the cations across their particular membranes. The α1-subunit of the 
Na+/K+-ATPase and the Ca2+-ATPase are ~100 kDa and thus migrate identically when 
applied to SDS-PAGE. In addition, these two pumps possess a similar 3-D structure (Morth 
et al., 2007; Toyoshima, 2000). Similar to SERCA, FITC labels Lys501 in the N-Domain of 
the α1-subunit of the Na+/K+-ATPase (Farley et al., 1984). Given the homology between 
these two pumps, it is highly probable that the Na+/K+-ATPase present in the HEK-293 cells 
may have been nitrosylated and/or oxidized following the ONOO- treatment. Clearly, if the 
whole microsomal fraction was separated by SDS-PAGE and probed for either FITC, 3-NY 
or reactive carbonyl groups, then it would have been impossible to discern whether the signal 




A secondary benefit of immunoprecipitating SERCA2a is that very little of the final 
immunoprecipitate was required to detect strong Western blot signals. In other words, the 
sample had been concentrated, which helped to improve detection of bands associated with 
FITC, 3-NY and reactive carbonyls on SERCA2a. Therefore, to determine the mechanisms 
responsible for ONOO- induced inactivation of SERCA2a and how overexpression of Hsp70 
protected SERCA2a function IP and several Western blotting techniques were employed.    
 
Assessment of 3-nitrotyrosine content on SERCA2a. 
It was hypothesized that ONOO- would increase 3-NY content in S2a-pMT2 cells. 
However, treatment of S2a-pMT2 HEK-293 cells with ONOO- did not increase 3-NY 
content on SERCA2a compared to the control S2a-pMT2 group. Furthermore, the 
overexpression of Hsp70 under control and ONOO- conditions had no effect on 3-NY 
content. Several studies have demonstrated that incubation of SERCA with ONOO- results in 
significant increases in 3-NY content (Gutiérrez-Martin et al., 2004; Viner et al., 1999b; 
Sharov et al., 2002). One study incubated SERCA1a with 0.1 and 0.25 mM ONOO- and 
observed a robust band at ~100 kDa when proteins were blotted for 3-NY content (Gutiérrez-
Martin et al., 2004). Such intense staining for 3-NY content on SERCA1a is surprising 
considering SERCA1a’s apparent resistance to nitrosylation when compared to SERCA2a 
(Sharov et al., 2002; Knyushko et al., 2005). Indeed, SERCA2a is more readily nitrosylated 
in vivo during biological ageing or in vitro following exposure to ONOO- (Viner et al., 
1999b; Knyushko et al., 2005).  
There are several possible explanations as to why 3-NY content was not altered 




sensitive enough to detect differences in 3-NY content. First, SERCA2a was 
immunoprecipitated and then blotted for 3-NY using an antibody specific for 3-NY residues. 
It is not known whether multiple antibodies can recognize multiple 3-NY residues on a single 
peptide or if only a single antibody can recognize one of many 3-NY residues on a single 
peptide. If the later is true, then it is not surprising that 3-NY content on SERCA2a did not 
change, since there appears to be a basal level of SERCA2a nitrosylation (Knyushko et al., 
2005).  
In young rats there is very little 3-NY residues detectable on SERCA2a (Tyr753) 
from skeletal muscle. However, in young cardiac muscle there are several nitrated Tyr 
residues (Tyr122, 130, 497, 586 & 990) (Knyushko et al., 2005). In aged rats the only 
significant increase in Tyr nitration occurs at the vicinal tyrosines, Tyr294 & Tyr295. These 
Tyr residues are in close proximity to the Ca2+ binding sites of SERCA2a and modification to 
these residues are believed to contribute to the reduction in Ca2+-ATPase activity observed 
with ageing (Knyushko et al., 2005). Selective nitrosylation of Tyr294 and Tyr295 would 
have been better detected using an antibody specifically designed to detect the nitration of 
these Tyr residues on SERCA2a (Xu et al., 2006). An even more sensitive measure of 3-NY 
formation on SERCAs requires the use of HPLC-tandem mass spectroscopy (Viner et al., 
2000; Sharov et al., 2006). This technique can not only determine the specific amino acids 
modified, but it can also determine the type of adduct formed on the amino acid residues (e.g. 
NO2-, GSS-, SNO-, etc.) (Adachi et al., 2004; Knyushko et al., 2005). The formation of 3-
NY may have taken place, but these tyrosine residues could have been further oxidized into 
tyrosyl radicals and then into bityrosines (Alvarez & Radi, 2003). This may explain the 




treatment with ONOO-. However, it is more likely that oxidation of amino acids (e.g. Cys) 
occurred before a substantial amount of 3-NY residues could accumulate. This is because 
only a single monomer band was present when SERCA2a was detected under reducing 
Western blot conditions. If SERCA2a formed bityrosines for example, reducing agents 
would not have been able to dissolve the SERCA2a aggregates and a high molecular weight 
band would have appeared on the Western blot (Viner et al., 1997). Also, it has been 
suggested that high concentrations of ONOO- are required to elicit significant nitrosylation of 
tyrosines (Denicola et al., 1998).   
 
Structural integrity of the N-domain as indicated by FITC binding to SERCA2a. 
It was hypothesized that incubation of S2a-pMT2 HEK-293 cells with 2.5 mM 
ONOO- would have reduced FITC binding to SERCA2a and that FITC binding would have 
been preserved in S2a-Hsp70 cells. However, no differences in FITC binding in either 
control or ONOO- treated groups were found. These results were surprising considering the 
evidence that suggests in vitro incubation of SERCA1a with ROS compromises the structural 
integrity of the N-domain. One study found that when SR isolated from fast-twitch skeletal 
muscle was incubated with HOCl that there was a concentration dependent decrease in Ca2+-
ATPase activity (Favero et al., 1998). This study also demonstrated that there was a HOCl 
concentration dependent decrease in the capacity of FITC to bind to SERCA1a, suggesting 
an association between the structural integrity of the N-domain and the ATPase activity of 
SERCA1a. An elegant study by Xu and colleagues (1997) demonstrated that pre-incubation 
of cardiac and skeletal SR with 1 mM ATP fully protected Ca2+-ATPase activity from ⋅OH 




binding pocket within the N-domain that ⋅OH is prevented from interacting with critical 
amino acids (i.e. Cys349) within that region and thus enzyme function is preserved. A study 
that measured FITC binding to SERCA1a demonstrated that heat shock of enriched SR at 
37oC resulted in a time-dependent reduction in the structural integrity of the N-domain 
(Tupling et al., 2004). A novel aspect of that study was that incubation with recombinant rat 
Hsp70 fully protected the N-domain for up to 60 min of heat stress. Similarly, FITC binding 
was reduced significantly in S2a-pMT2 HEK-293 cells following heat shock at 40oC for 1 hr 
(Fu & Tupling, unpublished results). However, when S2a-Hsp70 were expressed together, 
FITC labeling of SERCA2a was fully protected following heat stress. Modeling of SERCA1a 
and Hsp70 indicated that Hsp70 interacts with SERCA1a at or near the N-domain (Tupling et 
al., 2004). The current study was performed in living cells, in the presence of endogenous 
ATP and Hsp70, which may have been sufficient to prevent ONOO--induced damage to the 
N-domain of SERCA2a. These findings are unique compared with other studies and suggest 
that both ONOO--induced inactivation of SERCA2a and protection of SERCA2a by Hsp70 
can occur in the absence of structural modifications to the N-domain. This suggests that 
ONOO- modified amino acids in either the transmembrane, P- and/or A-domain and that 
Hsp70 can physically interact with SERCA2a in these regions. 
 
Hsp70 prevents oxidation of SERCA2a by ONOO-.  
It is possible that ONOO- interacted with SERCA2a in an area other than the N-
domain, such that FITC binding was not affected. The likelihood that amino acids were 
oxidized some distance from Lys514 (FITC binding site) is supported by the reactive 




reactive carbonyl groups (indication of protein oxidation) on SERCA2a by ~80%. The 
elevation in reactive carbonyl groups was completely abolished when Hsp70 was 
overexpressed in HEK-293 cells.  
Substantial evidence suggests that one of the primary mechanisms responsible for 
ROS/RNS induced inactivation of SERCA is protein oxidation. In particular oxidation of Cys 
residues on SERCA have been shown to associate with a reduction in enzyme activity 
(Favero et al., 1998; Scherer & Deamer, 1986; Kaplan et al., 2003). However, other studies 
have demonstrated that Cys oxidation was only partly responsible for the reduction in Ca2+-
ATPase activity (Viner et al., 1997; Gutiérrez-Martin et al., 2004). The oxidation of Cys 
residues is quite complex and can lead to several end products (e.g. Sulfenic acid, sulfinic 
acid, sulfonic acid, etc.) with a Cys RSSR bond being the most well observed end product 
(Alvarez & Radi, 2003).  
 
Site specific modification of oxidation of Cys on SERCA by ROS/RNS.  
Structural analysis of SERCA following exposure to ROS/RNS suggests that multiple 
Cys residues are oxidized depending on the assay conditions and that certain Cys residues 
may act as intrinsic antioxidants protecting other amino acids that are crucial for SERCA 
function (Viner et al., 2000; Sharov et al., 2006). A study by Viner et al. (1999a) found that 
low concentrations of ONOO- modified five Cys residues in a near 1:1 stoichiometry with the 
observed reduction in SERCA1a Ca2+-ATPase activity. Incubation with higher 
concentrations of ONOO- caused a ~40% loss in ATPase activity, which only correlated well 
with the modification of Cys344 and Cys349. These amino acids are proximal to Asp351 and 




of SERCA. Indeed, the proximity between Cys344 and Cys349; Cys670, Cys674 and Cys675 
or Cys876 and Cys888 makes them potential targets for RSSR formation (Viner et al., 2000). 
When SERCA1a was incubated with NO·, ONOO- or amino acid peroxides, it was 
demonstrated that the most highly oxidized Cys residues were Cys268, 349, 364, 471, 670, 
674, 675, 774 & 938 (Viner et al., 2000; Sharov et al., 2006; Dremina et al., 2007). From 
these Cys residues, only Cys471 is located within the N-domain sequence (Viner et al., 2000; 
MacLennan et al., 1985). Cys670, 674 and 675 are located within the hinge domain between 
the N-domain and M5. However, Cys674 and Cys675 are <12 Å away from Asp351, thus 
oxidation and formation of a RSSR bond between these residues could hinder 
aspartylphosphate formation (Sharov et al., 2006). Interestingly, Cys 268, 744 and 938 are 
located within M3, M5 and M9, respectively (Dremina et al., 2007). Oxidation of these Cys 
residues may influence the protein-lipid dynamics of SERCA with its surrounding 
membrane. 
Although Cys oxidation and SH content were not explicitly measured in the current 
study, it seems reasonable to speculate that some degree of the oxidation of SERCA2a was 
directed at Cys residues. Numerous studies have indicated that ONOO- reduced the number 
of free SH groups on SERCA (Gutiérrez-Martin et al., 2004; Sharov et al., 2006). Quite often 
the reduction of free thiols on SERCA is associated with the appearance of high molecular 
weight aggregates of SERCA. Studies have shown that ONOO-, diamide and AAPH reduced 
the amount of SH groups and increased the amount of high molecular weight aggregates of 
SERCA in a concentration- or time-dependent manner (Viner et al., 1999; Viner et al., 1997; 
Senisterra et al., 1997). Under control conditions, overexpression of Hsp70 reduced 




pMT2. However, SERCA2a aggregation increased in the S2a-pMT2 group following 
incubation with ONOO-, which was accompanied by a reduction in Vmax. Interestingly, 
ONOO- caused aggregation of SERCA2a in the S2a-Hsp70 group but to a lesser extent than 
the S2a-pMT2 group. These data suggest that lowering SERCA2a aggregation may not 
influence Vmax but if aggregation increases past a threshold then inactivation of SERCA2a 
occurs. This could explain, in part, the mechanism by which Hsp70 protected SERCA2a 
function. 
 
Potential mechanisms of Hsp70 protecting SERCA2a function.  
Several possible scenarios may explain how overexpression of Hsp70 preserved 
SERCA2a ATPase activity following exposure to ONOO-. The first is that Hsp70 may have 
buffered some of the nitrosative stress by reacting with ONOO-. When Hsp60 expression was 
knocked down in yeast, exposure to H2O2 increased reactive carbonyl content on several 
proteins, including Hsp60 (Cabiscol et al., 2002). Furthermore, incubation of GroEL with 
ONOO- significantly reduced its refolding activity. The main amino acid target on GroEL 
was oxidation of Met residues to methionine sulfoxide (Khor et al., 2004). Therefore, the 
possibility that ONOO- oxidized Hsp70 in the current study cannot be ruled out. 
The co-immunoprecipitation and Western blot data suggest that Hsp70 protected 
SERCA2a activity through a physical interaction that prevented oxidation and limited 
aggregation. In S2a-pMT2 cells, ONOO- increased the oxidation of SERCA2a by ~80%. 
This likely caused a conformational change in SERCA2a 3-D structure, which exposed 
hydrophobic amino acids to the cytosolic milieu (Senisterra et al., 1997). Detection of these 




bind to SERCA2a (Kumar & Mitra, 2005). At this point Hsp70 could have “held” SERCA2a 
without refolding it such that SERCA2a would not aggregate with other oxidized proteins 
(Mayer & Bukau, 2005), or Hsp70 would have refolded the partially denatured SERCA2a 
and restored its function.  
An alternative mechanism would involve SERCA2a forming inactive aggregates. 
Oxidation of SERCA2a increased the appearance of high molecular weight aggregates in the 
S2a-pMT2 group. Protein aggregates are toxic to the cell and are repaired quickly by 
molecular chaperones such as Hsp70 (Saibil, 2008). When Hsp70 was overexpressed in 
HEK-293 cells, exposure to ONOO- increased aggregation of SERCA2a. Presumably, this 
aggregation was detected by Hsp70 (or perhaps even Hsp40), which resulted in the 
recruitment of Hsp70 to disaggregate SERCA2a. Once bound to SERCA2a, Hsp70 would 
proceed through its reaction cycle changing its conformation in order to refold and/or pry 
apart SERCA2a. This process requires repeated cycles of Hsp70 binding to the substrate, 
hydrolysis of ATP, conformational changes within Hsp70’s tertiary structure and release of 
substrate from Hsp70 (Goloubinoff & De Los Rios, 2007). 
 
Model of the potential interaction sites between SERCA2a and Hsp70. 
 The arguments presented above support the hypothesis that ONOO- oxidized amino 
acid residues in a region other than the N-domain. Potential candidates are, Tyr294, 295 and 
753, as well as Cys674, 675 and 938 to name a few (Knyushko et al., 2005; Sharov et al., 
2006). Modeling of the potential interaction sites between SERCA1a and Hsp70 has been 
performed (Tupling et al., 2004). The SERCA1a-Hsp70 interactions predicted by Tupling et 




are illustrated in Figure 10. Interestingly, one of the most stable conformations of SERCA1a 
and Hsp70 had Hsp70 located juxtapose to the N-domain (Tupling et al., 2004). The middle 
image in Figure 10A is most intriguing, as it places Hsp70 in a region encompassing parts of 
the P-domain, A-domain and stalk region. This binding conformation is in accord with 
studies that suggest that Cys349 is a crucial amino acid with respect to SERCA catalytic 
activity (Xu et al., 1997; Viner et al., 2000). Also, Cys670, 674 and 675 have been shown to 
be modified by RNS and are in proximity to this proposed binding conformation of SERCA1 
and Hsp70 (Viner et al., 2000; Sharov et al., 2006). Other amino acids of interest are Tyr294, 
Ty295 and Cys938. These residues are intimate with the Ca2+ binding pocket and the protein-
lipid interface, respectively. Perhaps Hsp70 can interact with SERCA2a at the protein-lipid 
interface or even traverse the ER membrane to interact with luminal amino acids. Recent 
evidence suggests that Hsp70 can physically interact with acidic glycolipids and 
phospholipids (Harada et al., 2007). Furthermore, Hsp70 has been shown to insert in the 
plasma membrane of cells following cellular stress (Vega et al., 2008). A hypothetical 








    
Figure 10: Computer modeled and hypothetical interaction sites between SERCA1a 
and Hsp70. The upper panel depicts the most stable binding conformations of SERCA1a and 
Hsp70 determined by Tupling et al. J. Biol. Chem. 279(50): 52382-52389, 2004. The green 
ribbon is SERCA1a in the E2 conformation. The red ribbon and balls represent the substrate 
binding domain of bovine heat shock protein cognate and the Hsp70 binding site, 
respectively. The FITC binding site of SERCA1a (Lys515) is illustrated by the yellow balls. 
The lower panel depicts hypothetical binding of Hsp70 to SERCA2a (SERCA1a 3-D 
structure used) near the transmembrane domains (left and right images) or near the vicinal 




Physiological relevance of Hsp70 protecting SERCA2a. 
 Disruption in Ca2+ homeostasis is a functional consequence of exercise, ageing, 
certain disease states and in ischemia-reperfusion (IR). Each of these conditions shares a 
common thread, and that is the increased production of ROS/RNS (Kobzik et al., 1994; 
Zweier 1988; Ying et al., 2008). The ability to maintain Ca2+ homeostasis (i.e. protect 
SERCA function) in the face of oxidative stress could conceivably improve performance 
and/or recovery time or increase cell survivability. The current study sheds light on this issue 
by providing direct evidence that Hsp70 can preserve SERCA2a catalytic activity following 
exposure to highly reactive ONOO-. 
 
Summary. 
 In summary, this is the first study to demonstrate that physiological overexpression of 
Hsp70 can protect SERCA2a activity from incubation with exogenous ONOO- in cultured 
cells. ONOO- caused a ~20% reduction in SERCA2a Ca2+-ATPase activity, which was 
completely abrogated by Hsp70 overexpression. SERCA2a co-immunoprecipitated with 
Hsp70 under all of the experimental conditions in this study. It was hypothesized that 
ONOO- would increase 3-NY content and reduce FITC binding in the S2a-pMT2 group and 
that these structural modifications to SERCA2a would be prevented by Hsp70. However, 
there were no changes in 3-NY content and FITC binding in any of the four groups. The 
mechanisms associated with reduced SERCA2a activity were protein oxidation and 
aggregation. In the S2a-Hsp70 group, SERCA2a aggregation was reduced by ~44% when 
compared to the S2a-pMT2. When S2a-pMT2 was incubated with ONOO-, SERCA2a 




aggregation by ~30% in the S2a-Hsp70 group when compared to S2a-pMT2. Lastly, 
incubation of S2a-pMT2 cells with ONOO- caused a ~80% increase in the reactive carbonyl 
content of SERCA2a. The overexpression of Hsp70 completely prevented ONOO--induced 
oxidation of SERCA2a. 
 
Conclusion. 
The results of this thesis suggest that Hsp70 can protect SERCA2a from direct 
exposure to ONOO- by preventing ONOO--induced oxidation and aggregation of SERCA2a. 
This was accomplished through a physical interaction between SERCA2a and Hsp70. Hsp70 
likely bound to SERCA2a in a region some distance from the N-domain. In addition, binding 
of Hsp70 to SERCA2a help to limit the formation of high molecular weight aggregates, 
which was most likely from oxidation of Cys residues. This is the first study to demonstrate 
that Hsp70 can protect SERCA2a from direct attack from ONOO-.  
 
Limitations. 
 Due to the very low Ca2+-ATPase activity in the microsomal fractions, it was very 
difficult to achieve smooth, sigmoidal Ca2+-ATPase activity curve. That is not to say, 
however, that a clear Ca2+-dependence of Ca2+-ATPase activity was not observed. Sequential 
increases in the concentration of Ca2+ resulted in a step-wise increase in ATPase activity, 
which ultimately resulted in a subsequent decline in activity. Since, adequate sigmoidal Ca2+-
ATPase curves could not be generated this study was unable to comment or conclude on the 
effects of ONOO- on the cooperativity of Ca2+ binding to SERCA2a or the sensitivity of 




 This study utilized several Western blotting techniques to determine the mechanisms 
associated with ONOO--induced inactivation of SERCA2a. Although differences in reactive 
carbonyl content were observed, perhaps the use of more sensitive techniques (i.e. HPLC-
tandem MS) would have improved the understanding of how ONOO- reacted with SERCA2a 
in the current study. 
 Incubation with ONOO- was performed on living cells in culture. Every attempt was 
made to ensure that ONOO- was mixed throughout the entire volume of culture media. 
However, it is possible that groups of cells were exposed to higher concentrations of ONOO- 
compared to others. For example, the area where ONOO- was injected into culture would 
experience a sharp spike in the concentration of ONOO-, which may have severely damaged 
those cells whilst only moderately damaging other cells once ONOO- was mixed into the 
media. Furthermore, it is not known what concentration of ONOO- actually reacted with 
SERCA2a. It would likely be much less than what was added to the culture media, 
considering the distance needed for ONOO- to travel to interact with SERCA2a and the very 
short half life of ONOO- under physiological conditions (<0.1 sec). 
 
Future directions. 
 Future studies will examine isoform differences following incubation with ONOO-. 
More specifically, a direct comparison between SERCA1a and SERCA2a and the ability of 
Hsp70 to protect theses proteins from ONOO--induced inactivation should be examined. It 
would also be prudent to determine the threshold, if any, where Hsp70 can no longer protect 
SERCA2a function from increasing concentrations of ONOO-. In addition, the ability of 




Future studies will also look to extend these findings to the whole tissue/organ level. 
For example, preconditioning the heart with a mild stress results in a substantial increase in 
Hsp70 protein and provides cellular and functional protection from severe ischemia-
reperfusion. The rise in Hsp70 is necessary for cyto-protection following IR. The generation 
of ROS/RNS during IR would likely have deleterious effects on SERCA2a activity, which 
could lead to a significant rise in the [Ca2+]f. Calcium overload is a known inducer of 
apoptosis, which may contribute to the cellular damage and loss of function observed with 
severe IR. Perhaps Hsp70 can interact with SERCA2a in the preconditioned heart and 
prevent oxidative inactivation of SERCA2a. This hypothesis is somewhat contentious, as 
studies have provided evidence for and against this claim. Therefore, further examination of 
this topic is needed to elucidate the mechanisms by which Hsp70 protects the myocardium 
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Homogenizing buffer recipe 
 
Homogenizing buffer 
Reagent Molecular Weight (g/mol) Mass (g) Concentration (mM) 
Sucrose 342.3 85.575 250 
HEPES 238.3 1.1915 5 
PMSF 174.19 0.034838 0.2 
NaN3 65.01 2.0 0.2%* 
*NOTE: 1g solute per 100mL of H2O = 1% solution 
 
-Add PMSF to ~800 mL H2O in a beaker with magnetic stir bar. Cover with parafilm and stir 
on a hot plate set at a temperature of 35-40oC. 
 
-Once PMSF has dissolved add the remaining reagents and pH to 7.5 with KOH, bring to 1 L 








Reagent Concentration (M) Volume (μL) Temperature (
oC) Incubation Time (min) 
H2O2 10.3 1942 4 10 
NaOH 5 4000 4 10 
EDTA 0.04 500 4 10 
H2O ---- 500 4 10 
Isopentyl 
Nitrite 96% 5860 25 180 
 
-The first 4 reagents were combined in a beaker with a magnetic stir bar and mixed 
vigorously in an ice-water mixture for 10 minutes. 
 
-Subsequently, the beaker was removed from the ice-water mixture, isopentyl nitrite was 
added and the reaction proceeded for 180 min at room temperature. 
 
-The concentration of ONOO- was calculated using the extinction coefficient 1670 M-1 · cm-1 
and the following equation: 
 
(Abs. ONOO- 302nm – Abs. Blank)   1000 
-------------------------------------------   * 1000 * 2 *   -------  =  [ONOO-] mM 





Microsomal Ca2+-ATPase activity buffer 
 
Assay buffer 
Reagent Molecular Weight (g/mol) Mass (g) Concentration (mM) 
KCl 74.56 1.6024 100 
HEPES 238.3 1.0243 20 
NaN3 65.01 0.1397 10 
EGTA 380.4 0.08175 1 
MgCl2 95.21 0.2046 10 
PEP 465.3* 1.0 10 
*NOTE: The PEP used was a tricyclohexylammonium salt.  
 
-Combine all reagents in a beaker with magnetic stir bar and ~190 mL H2O. 
 
-Heat to >37oC and pH to 7.0 with KOH at 37oC. 
 





Buffers used for co-immunoprecipitation 
 
2X co-IP buffer 
Reagent Molecular Weight (g/mol) Mass (g) Concentration (mM) 
NaCl 58.44 0.4383 300 
HEPES 238.3 0.2383 40 
EDTA 372.24 0.01861 2 
MgCl2 95.21 0.0238 10 
1% Tween ---- 250 µL 1% 
PMSF* 174.19 400 µL 4 
*NOTE: A 250 mM stock solution of PMSF was made in EtOH just prior to use. 400 µL 
were added to the final volume to give a PMSF concentration of 4 mM. 
 
-In ~20 mL H2O combine all reagents and pH to 7.5. Bring to 25 mL and re-check pH. Store 
without PMSF (see note) at -20oC until use. 
 
1X co-IP buffer 
-This buffer contains the same reagents listed above, but at half the concentration. Therefore, 
mass the reagents accordingly. NOTE: 100 mL were made for these experiments. 
 
Wash buffer 
Reagent Molecular Weight (g/mol) Mass (g) Concentration (mM) 
NaCl 58.44 0.4383 150 
Tris 121.14 0.1514 25 




Reagent Molecular Weight (g/mol) Mass (g) Concentration (mM) 
Glycine 75.07 0.075 100 
-Add glycine to ~5 mL H2O, pH to 2.8, bring to 10 mL and re-check pH. Store at -20oC.  
 
Neutralizing buffer 
Reagent Molecular Weight (g/mol) Mass (g) Concentration (M) 
Tris 121.14 1.2114 1 





Buffers used for immunoprecipitation 
 
2X IP buffer 
Reagent Molecular Weight (g/mol) Mass (g) Concentration (mM) 
Tris 121.14 0.06057 20 
Sucrose 342.3 5.1345 600 
CHAPS 614.88 0.25 1% 
1 tablet of Complete© Roche protease inhibitor was added to the buffer 
-Add reagents to ~10-15mL H2O, pH to 7.4, bring to 25 mL and re-check pH. Store at -20oC. 
 
1X IP buffer 
-This buffer contains the same reagents listed above, but at half the concentration. Therefore, 





Buffers for FITC binding 
 
1X FITC non-denaturing lysis buffer 
Reagent Molecular Weight (g/mol) Mass (g) Concentration (mM) 
NaCl 58.44 0.17532 300 
Tris 121.14 0.06057 50 
EDTA 372.24 0.01861 5 
NaN3 65 0.002 0.02% 
Triton-X ---- 100 µL 1% 
PMSF* 174.19 40 µL 1 
*NOTE: A 250 mM stock solution of PMSF was made in EtOH just prior to use. 40 µL were 
added to the final volume to give a PMSF concentration of 1 mM. 
 
-Combine all reagents in ~8 mL H2O, pH to 7.4, bring to 10 mL and re-check pH. Store at     
-20oC. 
 
FITC binding buffer 
Reagent Molecular Weight (g/mol) Mass (g) Concentration (mM) 
Tris-HCl 157.6 0.788 50 
CaCl2 110.98 0.00111 0.1 
MgCl2 95.21 0.0476 5 
Sucrose 342.3 8.5575 250 
FITC 389.38 * 0.02 
1 tablet of Complete© Roche protease inhibitor was added to the buffer per 50 mL 
*NOTE: A FITC stock solution (6.42 mM) was made in ethanol and stored at -70oC until 
use. 
 
-Combine all reagents in ~70 mL H2O, pH to 8.8, bring to 100 mL and re-check pH. Store at 
-20oC 
 
-To achieve a FITC concentration of 0.02 mM, 3.12 µL of FITC were added to 997 µL of 





Buffers used for derivation of reactive carbonyls 
 
Derivatization buffer 
Reagent Molecular Weight (g/mol) Mass (g) Concentration (mM) 
2,4-DNPH 198.14 0.019814 10 
 




Reagent Molecular Weight (g/mol) Mass (g) Concentration (M) 
Tris 121.14 2.4228 2 
Glycerol ----- 3 mL 30% 
 
-Combine glycerol, ~2 mL H2O and Tris. Heat to ~40oC to help dissolve Tris. Bring to final 
volume with water, do not pH and store at -20oC. 
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